FR2331793B1 - - Google Patents

Info

Publication number
FR2331793B1
FR2331793B1 FR7633388A FR7633388A FR2331793B1 FR 2331793 B1 FR2331793 B1 FR 2331793B1 FR 7633388 A FR7633388 A FR 7633388A FR 7633388 A FR7633388 A FR 7633388A FR 2331793 B1 FR2331793 B1 FR 2331793B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7633388A
Other versions
FR2331793A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Co filed Critical General Electric Co
Publication of FR2331793A1 publication Critical patent/FR2331793A1/fr
Application granted granted Critical
Publication of FR2331793B1 publication Critical patent/FR2331793B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
FR7633388A 1975-11-13 1976-11-05 Methode de detection d'une reaction antigene-anticorps Granted FR2331793A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/631,727 US3984533A (en) 1975-11-13 1975-11-13 Electrophoretic method of detecting antigen-antibody reaction

Publications (2)

Publication Number Publication Date
FR2331793A1 FR2331793A1 (fr) 1977-06-10
FR2331793B1 true FR2331793B1 (fr) 1981-12-24

Family

ID=24532483

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7633388A Granted FR2331793A1 (fr) 1975-11-13 1976-11-05 Methode de detection d'une reaction antigene-anticorps

Country Status (5)

Country Link
US (1) US3984533A (fr)
JP (1) JPS5270018A (fr)
DE (1) DE2651388A1 (fr)
FR (1) FR2331793A1 (fr)
GB (1) GB1542493A (fr)

Families Citing this family (827)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055851B (it) * 1974-08-30 1982-01-11 Behringwerke Ag Particelle indicatirci per diagnosi in vitro
US3984533A (en) * 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4080264A (en) * 1976-03-01 1978-03-21 Massachusetts Institute Of Technology Immunoassay by light scattering spectroscopy
JPS5811575B2 (ja) * 1976-08-16 1983-03-03 帝国臓器製薬株式会社 抗原−抗体反応の測定法
US4208185A (en) * 1976-08-16 1980-06-17 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
US4203724A (en) * 1976-08-16 1980-05-20 Mitsubishi Chemical Industries Limited Method and apparatus for the measurement of antigens and antibodies
US4154669A (en) * 1977-02-11 1979-05-15 Pen Kem, Inc. Automatic electrophoresis apparatus
US4101220A (en) * 1977-03-31 1978-07-18 General Electric Company Laser Doppler spectroscopy with smoothened spectra line shapes
US4171956A (en) * 1977-06-13 1979-10-23 General Electric Company Laser immunoassay
US4197088A (en) * 1977-09-23 1980-04-08 Akro-Medic Engineering, Inc. Method for qualitative and quantitative determination of immunological reactions
US4411518A (en) * 1977-09-23 1983-10-25 Gamma Biologicals, Inc. Apparatus for use in qualitative determination of immunological reactions
US4191739A (en) * 1977-10-17 1980-03-04 General Electric Company Antigen-antibody reaction assay employing particle aggregation and resistive pulse analysis
DE2750521A1 (de) * 1977-11-11 1979-05-17 Behringwerke Ag Diagnostisches verfahren
US4102990A (en) * 1977-12-05 1978-07-25 General Electric Company Electrophoretic assay for antigen-antibody reaction based on particle-particle coupling
US4174952A (en) * 1978-01-23 1979-11-20 Massachusetts Institute Of Technology Immunoassay by light scattering intensity anisotropy measurements
JPS54108693A (en) * 1978-02-14 1979-08-25 Mitsubishi Chem Ind Method and device for optically measuring antigennantibody reaction
JPS54109494A (en) * 1978-02-16 1979-08-28 Teikoku Hormone Mfg Co Ltd Method of measuring antigennantibody reaction
US4222744A (en) * 1978-09-27 1980-09-16 Becton Dickinson & Company Assay for ligands
US4351709A (en) * 1979-02-28 1982-09-28 Goetz Philip J Method of obtaining the mean electrophoretic mobility of particles
US4217195A (en) * 1979-05-02 1980-08-12 General Electric Company Electrophoretic electrode for use in laser doppler shift spectroscopy, and method
JPS589060A (ja) * 1981-07-09 1983-01-19 Kureha Chem Ind Co Ltd 電気泳動法による細胞の検査方法
JPS60205263A (ja) * 1984-03-30 1985-10-16 Kureha Chem Ind Co Ltd 電気泳動法による細胞の検査方法
US5100805A (en) * 1989-01-26 1992-03-31 Seradyn, Inc. Quantitative immunoassay system and method for agglutination assays
US5108568A (en) * 1989-07-07 1992-04-28 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Controlled method of reducing electrophoretic mobility of macromolecules, particles or cells
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US5877028A (en) * 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5998220A (en) * 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US6168956B1 (en) 1991-05-29 2001-01-02 Beckman Coulter, Inc. Multiple component chromatographic assay device
US5137609A (en) * 1992-01-31 1992-08-11 Biometric Imaging Inc. Differential separation assay
US5874423A (en) * 1992-09-10 1999-02-23 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Digitalis-like compounds
US5869445A (en) * 1993-03-17 1999-02-09 University Of Washington Methods for eliciting or enhancing reactivity to HER-2/neu protein
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US6953573B1 (en) 1993-03-17 2005-10-11 University Of Washington Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US20040259113A1 (en) * 1993-07-22 2004-12-23 Mayo Foundation For Medical Education And Research, Hybritech Incorporated Method for detection of metastatic prostate cancer
US6103237A (en) * 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
WO1995030758A1 (fr) * 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Polypeptide hk2 recombine
AU2635295A (en) * 1994-06-13 1996-01-05 Henry Ford Health System A novel neuronal-neonatal gene: neuronatin
US6531277B2 (en) 1994-10-25 2003-03-11 The Curators Of The University Of Missouri Endometriosis-specific secretory protein
US5843673A (en) * 1994-10-25 1998-12-01 Curators Of The University Of Missouri Method of screening for endometriosis
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
US5777093A (en) * 1995-05-16 1998-07-07 Ramot-University Authority For Applied Research & Industrial Development Ltd. cDNAs associated with ataxia-telangiectasia
US5728807A (en) * 1995-05-16 1998-03-17 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Mutated proteins associated with ataxia-telangiectasia
US5858661A (en) 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US6942862B2 (en) * 1996-04-01 2005-09-13 University Of Washington Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
US6479263B1 (en) 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
US5840322A (en) * 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
WO1998059073A1 (fr) 1997-06-20 1998-12-30 Mayo Foundation For Medical Education And Research Procede de detection du cancer du sein
US20030104973A1 (en) * 1997-08-21 2003-06-05 Quark Biotech, Inc. Hypoxia-regulated genes
EP1009753B1 (fr) * 1997-08-21 2005-04-20 Quark Biotech, Inc. Genes regules au niveau de l'hypoxemie
US7973156B2 (en) * 1997-08-21 2011-07-05 Quark Pharmaceuticals Inc. Hypoxia-regulated genes
WO1999018438A1 (fr) * 1997-10-02 1999-04-15 Aclara Biosciences, Inc. Analyses capillaires impliquant la separation d'especes libres et liees
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
US6482389B1 (en) 1997-10-17 2002-11-19 University Of South Florida Method to diagnose and monitor cellular immune deficiencies
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US20080206206A1 (en) 1998-05-07 2008-08-28 University Of South Florida Bone marrow-derived neuronal cells
US6344443B1 (en) 1998-07-08 2002-02-05 University Of South Florida Peptide antagonists of tumor necrosis factor alpha
AU4994899A (en) 1998-07-13 2000-02-01 University Of South Florida Modulation of the phospholipase a2 pathway as a therapeutic
US6187563B1 (en) 1998-08-07 2001-02-13 Yale University βIV-spectrin-polypeptides and nucleic acids encoding same
EP1117762A4 (fr) 1998-09-29 2004-02-25 Gamida Cell Ltd Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
MXPA01007820A (es) 1999-02-04 2003-06-19 Technion Res & Dev Foundation Metodo y aparato para mantenimiento y expansion de celulas de tallo hemopoyeticas y/o celulas progenitoras.
US6440682B1 (en) * 1999-05-28 2002-08-27 Detroit R&D Inc. Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en) 1999-06-01 2004-09-07 Roskamp Research Institute, Llc Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US7534605B2 (en) 1999-06-08 2009-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
CA2377541A1 (fr) * 1999-06-25 2001-01-04 Eduardo N. Mitrani Procede permettant d'induire une angiogenese au moyen de micro-organes
US6875582B1 (en) 1999-08-19 2005-04-05 Omniscience Pharmaceuticals, Inc. Methods and targets of antibiotic resistance
US7101839B1 (en) 1999-08-30 2006-09-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
US7811981B2 (en) * 1999-08-30 2010-10-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of and compositions for inhibiting the proliferation of mammalian cells
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
NZ519043A (en) * 1999-11-19 2006-12-22 Yissum Res Dev Co Nucleic acid comprising a gene derived from Aspergillus niger that encodes a polypeptide that has a beta-glucosidase catalytic activity
US6544506B2 (en) 2000-01-05 2003-04-08 Yeda Research & Development Co. Ltd. Veto cells effective in preventing graft rejection and devoid of graft versus host potential
WO2001053323A2 (fr) * 2000-01-24 2001-07-26 Ramot University Authority For Applied Research & Industrial Development Ltd. Plantes tolerant le stress de l'environnement, procedes d'elaboration pour ce type de plante et sequence polynucleotidique utilisee a cet effet
US20040002068A1 (en) 2000-03-01 2004-01-01 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
ATE472601T1 (de) 2000-03-27 2010-07-15 Technion Res And Dev Of Founda Einkettige haupthistokompatibilitätskomplexe der klasse i (mhc-i), kodierende konstrukte und methoden ihrer erzeugung
IL135884A (en) * 2000-04-30 2005-08-31 Yissum Res Dev Co Method for measuring non-transferrin bound iron
HUP0300810A2 (hu) 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
EP1315519B1 (fr) 2000-08-08 2010-12-29 Technion Research And Development Foundation Ltd. Procedes et compositions pharmaceutiques permettant de traiter le cancer ou la fibrose hepatique
EP1683874A3 (fr) 2000-08-29 2006-10-11 YEDA RESEARCH AND DEVELOPMENT Co. LTD. Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
US7632522B2 (en) * 2000-09-28 2009-12-15 Nanocyte Inc. Use of stinging cells/capsules for the delivery of active agents to keratinous substances
WO2002026191A2 (fr) 2000-09-28 2002-04-04 Nanocyte Inc. Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
US20070281037A9 (en) * 2000-09-28 2007-12-06 Nanocyte Inc. Sterile preparations and compositions including stinging capsules and methods of producing and using same
ES2338529T3 (es) 2000-11-17 2010-05-10 Vascular Biogenics Ltd. Prometores que exiben especificidad por celulas endoteliales y metodos para su utilizacion.
US8071740B2 (en) 2000-11-17 2011-12-06 Vascular Biogenics Ltd. Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
CA2429817C (fr) 2000-11-24 2013-02-12 Vascular Biogenics Ltd. Procedes faisant appels a des phospholipides oxydes definis, ainsi que compositions contenant ces derniers, pour la prevention et le traitement de l'atherosclerose
AU2002221013A1 (en) * 2000-11-30 2002-06-11 Yeda Research And Development Co..Ltd. Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
EP1356298B1 (fr) 2000-11-30 2011-05-18 Crawford Healthcare Holdings Limited Diagnostic de maladie
JP2004526431A (ja) * 2001-01-17 2004-09-02 ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド 食虫植物に由来するキチナーゼ、該キチナーゼをコードするポリヌクレオチド配列、ならびに該キチナーゼを単離および使用する方法
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
AU2002230061A1 (en) * 2001-01-31 2002-08-12 Tolaren Induction of tolerance by apoptotic and/or necrotic cells
GB0103611D0 (en) * 2001-02-14 2001-03-28 Zetatronics Ltd Further improved method for detecting cells
US20030003454A1 (en) 2001-03-23 2003-01-02 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US6770622B2 (en) 2001-06-08 2004-08-03 Gary A. Jarvis N-terminally truncated galectin-3 for use in treating cancer
EP1414838A4 (fr) * 2001-07-19 2005-12-14 Yissum Res Dev Co Polypeptides possedant une activite catalytique d'isomerase de carotenoides, acides nucleiques codant pour ces polypeptides et applications de ceux-ci
CA2458640A1 (fr) 2001-08-16 2003-03-06 Bar-Ilan University Diagnostic, prevention et traitement du cancer
US20040136972A1 (en) 2001-09-07 2004-07-15 Yeda Research And Development Co. Ltd. Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
US20060068405A1 (en) * 2004-01-27 2006-03-30 Alex Diber Methods and systems for annotating biomolecular sequences
JP4173446B2 (ja) 2001-10-19 2008-10-29 ヴァスキュラー バイオジェニックス リミテッド 血管形成の標的化されたダウンレギュレーションおよび抗ガン治療のためのポリヌクレオチド構築物および薬学的組成物および方法
AU2002358947A1 (en) * 2001-12-05 2003-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
US20050085432A1 (en) * 2001-12-26 2005-04-21 Aviva Lapidot Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (fr) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
US7781396B2 (en) * 2002-01-31 2010-08-24 Tel Aviv University Future Technology Development L.P. Peptides directed for diagnosis and treatment of amyloid-associated disease
US20040052928A1 (en) * 2002-09-06 2004-03-18 Ehud Gazit Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US6992176B2 (en) 2002-02-13 2006-01-31 Technion Research & Development Foundation Ltd. Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
EP3031910B1 (fr) 2002-02-21 2017-08-16 Institute Of Virology Anticorps monoclonaux spécifiques au mn/ca ix générés à partir de souris déficientes en mn/ca ix et procédés d'utilisation
EP1485464A4 (fr) * 2002-03-18 2006-11-29 Gamida Cell Ltd Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
AU2003215878A1 (en) * 2002-03-26 2003-10-08 Nanocyte Inc. Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US20040121442A1 (en) * 2002-05-05 2004-06-24 Ilan Chet Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
JP2005533102A (ja) * 2002-07-12 2005-11-04 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 微小器官によって生物学的プロセスを誘発する方法と装置
ES2449115T3 (es) 2002-08-01 2014-03-18 Yeda Research And Development Co., Ltd. Método y composición para proteger el tejido neuronal de lesiones inducidas por niveles de glutamato elevados
US7267981B2 (en) 2002-10-07 2007-09-11 Technion Research & Development Foundation Ltd. Human foreskin fibroblasts for culturing ES cells
WO2004037204A2 (fr) * 2002-10-25 2004-05-06 University Of South Florida Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
WO2004040252A2 (fr) 2002-10-30 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Molecules et leurs procedes d'utilisation pour la mesure de fer non lie par la transferrine
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
US7947499B2 (en) * 2002-11-29 2011-05-24 Technion Research & Development Foundation Ltd. Method of dynamically culturing embryonic stem cells
US7491699B2 (en) 2002-12-09 2009-02-17 Ramot At Tel Aviv University Ltd. Peptide nanostructures and methods of generating and using the same
DE60334846D1 (de) 2002-12-12 2010-12-16 R B T Rakuto Bio Technologies VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
JP4613069B2 (ja) 2002-12-16 2011-01-12 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 支持細胞非含有、異種非含有のヒト胚性幹細胞の調製方法およびこれらを使用して調製された幹細胞培養物
JP2006512079A (ja) 2003-01-02 2006-04-13 ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ 高血糖性患者の心疾患を予防するための抗酸化治療の有効性を予測する方法
EP2058275A1 (fr) * 2003-01-07 2009-05-13 Ramot at Tel-Aviv University Ltd. Nanostructures de peptides encapsulant un matériau étranger et leur procédé de fabrication
EP2319857A3 (fr) 2003-03-04 2012-06-27 Yeda Research And Development Co., Ltd. Polypeptides pon, polynucleotides les codant et compositions et procédés utilisant ces derniers
CA2517959A1 (fr) * 2003-03-07 2004-09-16 Gamida-Cell Ltd. Extension de populations de cellules souches renouvelables au moyen de modulateurs de kinase pi 3
US8017113B2 (en) 2003-03-12 2011-09-13 Rappaport Family Institute For Research In The Medical Sciences Compositions and methods for diagnosing and treating an inflammation
US7294701B2 (en) * 2003-04-02 2007-11-13 Technion Research & Development Foundation Ltd. Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
ES2369498T3 (es) 2003-04-04 2011-12-01 Yeda Research And Development Co., Ltd. Anticuerpos para inhibir la actividad de mmp-2 y mmp-9.
ES2559053T3 (es) 2003-04-08 2016-02-10 Yeda Research And Development Co., Ltd. Células madre con aumento de sensibilidad a SDF-1 y procedimientos de generación y utilización de las mismas
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US7554007B2 (en) 2003-05-22 2009-06-30 Evogene Ltd. Methods of increasing abiotic stress tolerance and/or biomass in plants
AU2005234725B2 (en) 2003-05-22 2012-02-23 Evogene Ltd. Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
CN100591770C (zh) 2003-05-22 2010-02-24 伊沃基因有限公司 提高植物非生物胁迫耐受性和/或生物量的方法及用该方法所产生的植物
US7498428B2 (en) * 2003-06-19 2009-03-03 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US8129514B2 (en) * 2003-06-19 2012-03-06 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
CN101415724B (zh) 2003-06-30 2015-12-02 特拉维夫大学未来科技开发有限公司 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法
JP2007518394A (ja) * 2003-08-14 2007-07-12 ザ バイオ バランス コーポレイション 細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
EP1663199B1 (fr) 2003-09-25 2013-04-03 Tel Aviv University Future Technology Development L.P. Compositions et methodes d'utilisation de ces compositions pour le traitement des maladies associees a la substance amyloide
US7625707B2 (en) 2003-10-02 2009-12-01 Ramot At Tel Aviv University Ltd. Antibacterial agents and methods of identifying and utilizing same
IL158287A0 (en) 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
WO2005033145A1 (fr) 2003-10-07 2005-04-14 Yeda Research And Development Co. Ltd. Anticorps diriges contre nik, preparation et emploi
MXPA06004537A (es) * 2003-10-23 2006-06-23 Pfizer Prod Inc Vacuna para la enfermedad periodontal.
CA2547459C (fr) 2003-11-30 2013-10-08 Yeda Research And Development Co. Ltd Procedes et agents pour mettre en oeuvre une modulation immunitaire et procedes d'identification de modulateurs immunitaires
WO2005059100A2 (fr) * 2003-12-12 2005-06-30 New York University Procedes et compositions se rapportant a la cystatine c
US20100221233A1 (en) * 2003-12-15 2010-09-02 University Of South Florida Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
EP2289567A3 (fr) 2003-12-22 2011-06-22 Regentis Biomaterials Ltd. Matrice à base de protéines naturelles réticulées
US8007847B2 (en) 2004-01-13 2011-08-30 Eytan Biderman Feeding formula appliance
US7423139B2 (en) * 2004-01-20 2008-09-09 Insight Biopharmaceuticals Ltd. High level expression of recombinant human erythropoietin having a modified 5′-UTR
US7456149B2 (en) 2004-03-02 2008-11-25 Acceleron Pharma, Inc. ALK7 and myostatin inhibitors and uses thereof
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US7771660B2 (en) * 2004-05-04 2010-08-10 University Of North Carolina At Chapel Hill Electrophoretic interactive spectral methods and devices for the detection and/or characterization of biological particles
ES2665463T3 (es) 2004-06-14 2018-04-25 Evogene Ltd. Polinucleótidos y polipéptidos implicados en el desarrollo de fibra vegetal y métodos de uso de los mismos
US8680062B2 (en) 2004-07-06 2014-03-25 Deliversir Ltd. System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en) * 2004-07-15 2009-06-18 Ramot At Tel Aviv University Ltd. Use of anti-amyloid agents for treating and typing pathogen infections
EP1781310B1 (fr) * 2004-08-02 2015-10-14 Ramot at Tel Aviv University Ltd. Articles de nanostructures a base de peptides et leur procede de formation
US7786086B2 (en) 2004-09-08 2010-08-31 Ramot At Tel-Aviv University Ltd. Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
EP1799812A4 (fr) 2004-09-16 2009-09-09 Gamida Cell Ltd Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
NZ554787A (en) 2004-09-29 2009-05-31 Collplant Ltd Collagen producing plants and methods of generating and using same
WO2006035439A2 (fr) * 2004-09-29 2006-04-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Rnase t2 humaine recombinee et utilisations associees
EP1809374A4 (fr) * 2004-10-12 2008-09-10 Closed Loop Therapies Ltd Methodes et dispositifs implantables pour traiter des arythmies supraventriculaires
IL165484A0 (en) 2004-11-30 2006-01-15 Applied Research Systems Production of proteins
US20060134680A1 (en) * 2004-12-22 2006-06-22 Alexander Kotlyar Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
US8375327B2 (en) * 2005-01-16 2013-02-12 Zlango Ltd. Iconic communication
JP2008529325A (ja) * 2005-01-16 2008-07-31 ズランゴー リミテッド 通信ネットワークシステムおよびそれを使用するための方法
ES2562406T3 (es) 2005-01-31 2016-03-04 Realbio Technologies Ltd. Dispositivo capilar de flujo lateral de reacción multietapa
AU2006215300C9 (en) 2005-02-17 2010-05-06 Hadasit Medical Research Services And Development Ltd. Bisphosphonates for treating endometriosis
US8216801B2 (en) 2005-02-25 2012-07-10 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center Methods for treating inflammatory disorders
US7695927B2 (en) * 2005-03-18 2010-04-13 Detroit R & D Detection of hypertension using glucuronidated metabolic products
US20090068207A1 (en) * 2005-04-15 2009-03-12 Vascular Biogenics Ltd. Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
US8834862B2 (en) * 2005-04-19 2014-09-16 Nanocyte Inc. Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
EP1888034A2 (fr) 2005-05-26 2008-02-20 Yissum Research Development Company, of The Hebrew University of Jerusalem Compositions et methodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protege par une barriere sanguine
ES2524996T3 (es) 2005-06-16 2014-12-16 Ramot At Tel Aviv University Ltd. Células aisladas y poblaciones que comprenden a las mismas para el tratamiento de enfermedades del SNC
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
WO2007007317A1 (fr) * 2005-07-07 2007-01-18 Yissum Research Development Company Of The Hebrew University Of Jerusalem Agents de type acide nucleique pour la regulation a la baisse de h19 et methodes d'emploi desdits agents
JP5086254B2 (ja) 2005-07-07 2012-11-28 フルクルム エスピー リミテッド Ｓｐ１ポリペプチド、変性ｓｐ１ポリペプチドおよびそれらの使用
CN101278052A (zh) 2005-07-18 2008-10-01 普罗塔里克斯有限公司 生物活性大分子的粘膜或肠给药
CA2615460A1 (fr) * 2005-08-08 2007-02-15 Onconon, Llc Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
EP1928479B1 (fr) 2005-08-24 2016-06-08 Yeda Research And Development Co., Ltd. Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
US8476070B2 (en) 2005-08-29 2013-07-02 Technion Research & Development Foundation Limited Media for culturing stem cells
DE602006014009D1 (de) 2005-09-22 2010-06-10 Yissum Res Dev Co Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
US10004828B2 (en) * 2005-10-11 2018-06-26 Romat at Tel-Aviv University Ltd. Self-assembled Fmoc-ff hydrogels
US20070087437A1 (en) * 2005-10-14 2007-04-19 Jifan Hu Methods for rejuvenating cells in vitro and in vivo
BRPI0618965B1 (pt) 2005-10-24 2021-01-12 Evogene Ltd método para aumentar a tolerância de uma planta a uma condição de estresse abiótico, método para aumentar a biomassa, vigor e/ou rendimento de uma planta, método para aumentar a eficiência do uso de fertilizante e/ou absorção de uma planta
AU2006308765B2 (en) 2005-11-02 2013-09-05 Arbutus Biopharma Corporation Modified siRNA molecules and uses thereof
US7879212B2 (en) * 2005-11-03 2011-02-01 Ramot At Tel-Aviv University Ltd. Peptide nanostructure-coated electrodes
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
BRPI0620523A2 (pt) 2005-11-29 2011-11-16 Gamida Cell Ltd método de aumentar o potencial de implante e de atração celular, método de preparar células para transplante em um sujeito, população de células e composição farmacêutica
EP1977312A2 (fr) 2006-01-16 2008-10-08 Zlango Ltd. Communication iconique
EP1982450A2 (fr) * 2006-01-16 2008-10-22 Zlango Ltd. Systeme de reseau de communication et ses procedes d'utilisation
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8759292B2 (en) 2006-02-03 2014-06-24 Prolor Biotech, Llc Long-acting coagulation factors and methods of producing same
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
WO2007092252A2 (fr) 2006-02-03 2007-08-16 Modigene Inc Polypeptides a action prolongee et leurs procedes de production
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
JP2009526219A (ja) 2006-02-06 2009-07-16 ラパポート ファミリー インスティテュート フォー リサーチ イン ザ メディカル サイエンシーズ Ｔ１ｄｍを診断するための方法及びキット
CA2641954C (fr) 2006-03-06 2016-04-26 Zetiq Technologies Ltd. Procedes et compositions pour identifier un phenotype cellulaire
SG170761A1 (en) 2006-03-23 2011-05-30 Pluristem Ltd Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007110869A2 (fr) 2006-03-28 2007-10-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Procedes et kits pour determiner la predisposition a la resistance a la warfarine
KR20090029184A (ko) * 2006-04-07 2009-03-20 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 항체 조성물 및 신생물성 질병의 치료 방법
US20100196336A1 (en) 2006-05-23 2010-08-05 Dongsu Park Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
US20070281883A1 (en) * 2006-06-05 2007-12-06 Hanna Rosenfeld Development of follicle stimulating hormone agonists and antagonists in fish
US8629259B2 (en) 2006-07-20 2014-01-14 Yeda Research And Development Co. Ltd. Photosynthetic organisms and compositions and methods of generating same
WO2008026198A2 (fr) 2006-08-28 2008-03-06 Yeda Research And Development Co. Ltd. Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
US7888059B2 (en) * 2006-10-05 2011-02-15 Yeda Research And Development Co. Ltd. Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
WO2008041183A2 (fr) 2006-10-05 2008-04-10 Technion Research & Development Foundation Ltd. Microtubes et leurs procédés de fabrication
BRPI0719602B1 (pt) * 2006-12-20 2021-05-18 Evogene Ltd construção de ácido nucléicos, e, métodos para aumentar biomassa de uma planta, para aumentar o vigor de uma planta, para aumentar o rendimento de uma planta, para aumentar a tolerância de uma planta ao stress abiótico, para aprimorar a qualidade de fibra e/ou rendimento de uma planta que produz fibra e para produzir fibras de algodão
CA2675967A1 (fr) * 2007-01-16 2008-07-24 Yissum Research Development Company Of The Hebrew University Of Jerusale M Acides nucleiques recombines et procedes de silencage specifique de h19
US20100196403A1 (en) * 2007-01-29 2010-08-05 Jacob Hochman Antibody conjugates for circumventing multi-drug resistance
EP2117616A2 (fr) 2007-01-31 2009-11-18 Technion Research & Development Foundation Ltd. Échafaudages électrofilés et leurs procédés de génération et d'utilisation
CA2676932C (fr) 2007-02-01 2015-11-24 Technion Research & Development Foundation Ltd. Fibres et tissus d'albumine et leurs procedes de generation et d'utilisation
JP2010517529A (ja) 2007-02-02 2010-05-27 アムジエン・インコーポレーテツド ヘプシジン及びヘプシジン抗体
ES2662036T3 (es) 2007-02-28 2018-04-05 Yeda Research And Development Company Limited Secuencias que se dirigen al núcleo
CA2682093A1 (fr) 2007-03-29 2008-10-09 Technion Research & Development Foundation Ltd. Anticorps, procedes et kits de diagnostic et de traitement de melanomes
KR20100015774A (ko) 2007-04-02 2010-02-12 라모트 앳 텔-아비브 유니버시티 리미티드 암세포 검출 방법 및 그 질병의 진단 및 그 질병의 치료의 모니터링을 위한 상기 방법의 용도
CN101854798B (zh) 2007-04-09 2013-04-03 伊沃基因有限公司 用于增加植物的油含量、生长速率和/或产量的多核苷酸、多肽和方法
US9156865B2 (en) 2007-04-23 2015-10-13 Deliversir Ltd System for delivering therapeutic agents into living cells and cells nuclei
US9556210B2 (en) 2007-04-23 2017-01-31 Sabag-Rfa Ltd. System for delivering therapeutic agents into living cells and cells nuclei
PL2144633T3 (pl) * 2007-04-23 2015-02-27 Sabag Rfa Ltd Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
ES2564312T3 (es) 2007-05-01 2016-03-21 Tel Hashomer Medical Research Infrastructure And Services Ltd. Métodos y kits para detectar células fetales en la sangre materna
DK3360571T3 (da) 2007-05-03 2021-01-04 Agency For Science Tech And Research Astarstar Antistoffer, der binder til et intracellulært PRL-1- eller PRL-3-polypeptid
SG187447A1 (en) 2007-05-07 2013-02-28 Protalix Ltd Large scale disposable bioreactor
EP2176409B1 (fr) 2007-07-11 2012-01-04 Yeda Research And Development Co. Ltd. Systèmes de produits de construction d'acide nucléique pouvant diagnostiquer ou traiter un état cellulaire
IL184627A0 (en) 2007-07-15 2008-12-29 Technion Res & Dev Foundation Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
CA2696833A1 (fr) 2007-07-15 2009-01-22 Yitzchak Hillman Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
WO2009013750A2 (fr) 2007-07-24 2009-01-29 Evogene Ltd. Polynucléotides, polypeptides codés par ceux-ci, et leurs procédés d'utilisation pour augmenter la tolérance au stress abiotique et/ou la biomasse et/ou le rendement dans des plantes les exprimant
WO2009017833A2 (fr) 2007-08-02 2009-02-05 Arresto Biosciences Procédés et compositions de traitement et de diagnostic de fibrose, d'invasion tumorale, d'angiogenèse et de métastase
MX2010001657A (es) 2007-08-15 2010-03-15 Yeda Res & Dev Reguladores de mmp-9 y usos de los mismos.
WO2009034574A2 (fr) 2007-09-12 2009-03-19 Yeda Research And Development Co. Ltd. Procédés de traitement de tumeurs dans des sites privilégiés immunitairement
CN107050057B (zh) 2007-09-19 2021-04-20 普拉里斯坦有限公司 来自脂肪或胎盘组织的粘附细胞及其在治疗中的用途
ES2505440T3 (es) 2007-10-19 2014-10-09 Rappaport Family Institute For Research In The Medical Sciences Composiciones que comprenden semaforinas para el tratamiento de las enfermedades relacionadas con la angiogénesis y los procedimientos de selección de las mismas
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
WO2009069123A2 (fr) 2007-11-26 2009-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions renfermant des polypeptides fibreux et des polysaccharides
CA2709517C (fr) 2007-12-27 2019-02-26 Evogene Ltd. Polypeptides isoles, polynucleotides utiles pour modifier l'efficacite de l'utilisation de l'eau, l'efficacite de l'utilisation de fertilisant, la tolerance au stress biotique/abiotique, le rendement et la biomasse chez les plantes
EP2238251B1 (fr) 2007-12-27 2015-02-11 Protiva Biotherapeutics Inc. Silençage de l'expression de la polo-like kinase à l'aide d'un arn interférent
WO2009094551A1 (fr) 2008-01-25 2009-07-30 Amgen Inc. Anticorps anti-ferroportine et procédés d'utilisation
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
WO2009104176A2 (fr) 2008-02-21 2009-08-27 Technion Research & Development Foundation Ltd. Méthodes de liaison d'une molécule d'intérêt à un microtube
NZ588583A (en) 2008-04-15 2012-08-31 Protiva Biotherapeutics Inc Novel lipid formulations for nucleic acid delivery
CA2721380A1 (fr) 2008-04-15 2009-10-22 Protiva Biotherapeutics, Inc. Reduction au silence de l'expression du gene csn5 au moyen d'arn interferant
ES2565185T3 (es) 2008-04-18 2016-04-01 Collplant Ltd. Métodos de generación y de uso del procolágeno
AU2009239333A1 (en) 2008-04-21 2009-10-29 Danziger Innovations Ltd. Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
EP2816059A1 (fr) 2008-05-01 2014-12-24 Amgen, Inc Anticorps anti-hepcidine et procédés d'utilisation
EP2116618A1 (fr) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnostic et traitement de la maladie de Kawasaki
BRPI0908666B1 (pt) 2008-05-22 2021-06-15 Evogene Ltd Método de aumento do teor do óleo, do rendimento de sementes, da taxa de crescimento e/ou da biomassa de uma planta quando comparada a uma planta nativa, e, construção de ácido nucleico isolado
EP2303293A1 (fr) 2008-05-27 2011-04-06 Pluristem Ltd. Procédés de traitement de maladies inflammatoires du côlon
WO2009144718A1 (fr) 2008-05-28 2009-12-03 Ramot At Tel Aviv University Ltd. Cellules souches mésenchymateuses destinées au traitement de troubles du snc
US9952211B2 (en) 2008-06-29 2018-04-24 Realbio Technologies Ltd. Liquid-transfer device particularly useful as a capturing device in a biological assay process
EP2320953B1 (fr) 2008-08-08 2015-07-15 Genisphere, LLC Dendrimères d'adn à longue durée d'action et méthodes afférentes
WO2010016806A1 (fr) 2008-08-08 2010-02-11 Agency For Science, Technology And Research (A*Star) Vhz pour le diagnostic et le traitement de cancers
EP3072972B1 (fr) 2008-08-18 2019-10-23 Evogene Ltd. Polypeptides et polynucléotides isolés utiles pour augmenter l'efficacité de l'utilisation de l'azote, la tolérance au stress abiotique, le rendement et la biomasse de plantes
MX2011002328A (es) 2008-09-02 2011-05-19 Pluristem Ltd Celulas adherentes del tejido de placenta y su uso en terapia.
US8367392B2 (en) * 2008-09-05 2013-02-05 Transalgae Ltd. Genetic transformation of algal and cyanobacteria cells by microporation
WO2010029545A2 (fr) 2008-09-11 2010-03-18 Ben Gurion University Of The Negev Research And Development Authority Compositions et procédés destinés à traiter une infection par s. pneumoniae
RU2535966C2 (ru) 2008-09-12 2014-12-20 Криопрашис Криобиоложия Лтда. Клеточная терапия ишемической ткани
EP3670524A1 (fr) 2008-09-24 2020-06-24 Tel HaShomer Medical Research Infrastructure and Services Ltd. Peptides et compositions pour la prévention de l'adhésion cellulaire et leurs procédés d'utilisation
CA2736729A1 (fr) 2008-09-29 2010-04-01 Ben Gurion University Of The Negev Research And Development Authority Beta-peptides amyloides et procedes d'utilisation associes
MX2011003575A (es) 2008-10-30 2011-04-21 Evogene Ltd Polinucleotidos y polipeptidos aislados y metodos para utilizarlos para aumentar el rendimiento de la planta, biomasa, tasa de crecimiento, vigor, contenido de aceite, tolerancia al estres abiotico de las plantas y eficacia en el uso de nitrogeno.
US20110229892A1 (en) 2008-11-17 2011-09-22 Yehuda G Assaraf Method for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (fr) 2008-11-19 2010-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
WO2010061383A1 (fr) 2008-11-26 2010-06-03 Biodalia Microbiological Technologies Ltd. Procédé permettant d’enrichir in-situ des aliments avec des fructanes
WO2010064231A1 (fr) 2008-12-02 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
WO2010064247A1 (fr) 2008-12-03 2010-06-10 Tel Hashomer Medical Research Infrastructure And Services Ltd. Procédés et trousses pour déterminer une prédisposition au cancer
WO2010064248A2 (fr) 2008-12-05 2010-06-10 Yeda Research And Development Co. Ltd. Procédés de diagnostic et de traitement des maladies des motoneurones
WO2010071610A1 (fr) 2008-12-19 2010-06-24 Agency For Science, Technology And Research (A*Star) Marqueurs biologiques de chikungunya sévère
US20120009148A1 (en) 2008-12-29 2012-01-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
EP2373792B1 (fr) 2008-12-29 2016-11-02 Evogene Ltd. Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique, la biomasse et/ou le rendement dans les plantes les exprimant
CA2748121C (fr) 2008-12-29 2017-12-12 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptides et compositions pour prevenir l'adhesion cellulaire et leurs procedes d'utilisation
WO2010076794A1 (fr) 2008-12-31 2010-07-08 Technion Research & Development Foundation Ltd. Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
WO2010080769A2 (fr) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Procédés et compositions chimiothérapeutiques
IL196820A0 (en) 2009-02-01 2009-11-18 Yissum Res Dev Co Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
US8691760B2 (en) 2009-02-02 2014-04-08 Ramot At Tel-Aviv University Peptides, pharmaceutical compositions comprising same and uses thereof
WO2010089707A1 (fr) 2009-02-04 2010-08-12 Yeda Research And Development Co. Ltd. Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
US20110311494A1 (en) 2009-02-26 2011-12-22 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods of reprogramming renal cells
WO2010100595A2 (fr) 2009-03-02 2010-09-10 Evogene Ltd. Polynucléotides et polypeptides isolés, et procédés d'utilisation de ceux-ci pour augmenter un rendement végétal et/ou des caractéristiques agricoles
ES2564265T3 (es) 2009-03-09 2016-03-21 Ramot At Tel-Aviv University Ltd. Composiciones para prevención y tratamiento de enfermedades neurodegenerativas
WO2010103517A1 (fr) 2009-03-12 2010-09-16 Rappaport Family Institute For Research In The Medical Sciences Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
EP2414542B1 (fr) 2009-03-30 2017-08-30 Tel HaShomer Medical Research Infrastructure and Services Ltd. Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
WO2010113146A1 (fr) 2009-04-01 2010-10-07 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Procédé de régulation de la prolifération et de la différenciation des kératinocytes
WO2010116375A1 (fr) 2009-04-08 2010-10-14 Yeda Research And Development Co. Ltd. Peptides isolés pour réguler l'apoptose
KR20180077322A (ko) 2009-04-30 2018-07-06 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． 항-ｃｅａｃａｍ1 항체들과 이를 이용하는 방법들
WO2010134073A1 (fr) 2009-05-19 2010-11-25 Zetiq Technologies Ltd. Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
WO2010137021A2 (fr) 2009-05-27 2010-12-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de génération de tissu conjonctif
WO2010137017A2 (fr) 2009-05-27 2010-12-02 Yeda Research And Development Co. Ltd. Inhibiteurs des protéasomes et leurs utilisations
WO2010137013A1 (fr) 2009-05-27 2010-12-02 Ramot At Tel Aviv University Ltd. Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
US20120070449A1 (en) 2009-05-28 2012-03-22 Yeda Research And Development Co. Ltd. Methods of treating inflammation
ES2773985T3 (es) 2009-06-10 2020-07-16 Evogene Ltd Polinucleótidos y polipéptidos aislados, y métodos para usar los mismos para incrementar la eficiencia en el uso de nitrógeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite, y/o tolerancia al estrés abiótico
IN2012DN00715A (fr) 2009-06-24 2015-06-19 Health Corp Rambam
WO2011000107A1 (fr) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Formulations lipidiques inédites permettant l'administration d'agents thérapeutiques en direction de tumeurs solides
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
WO2011004379A1 (fr) 2009-07-10 2011-01-13 Tel Hashomer Medical Research Infrastructure And Services Ltd. Compositions et méthodes de traitement du cancer
US8716464B2 (en) 2009-07-20 2014-05-06 Thomas W. Geisbert Compositions and methods for silencing Ebola virus gene expression
AU2010274581B2 (en) 2009-07-21 2014-05-01 Tel Hashomer Medical Research Infrastructure And Services Ltd. A method of diagnosing cancer
GB0913442D0 (en) 2009-07-31 2009-09-16 Univ Ramot Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
EP2467470A2 (fr) 2009-08-17 2012-06-27 Technion Research & Development Foundation Ltd. Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
KR20120063488A (ko) 2009-08-21 2012-06-15 길리아드 바이오로직스, 인크. 리실 옥시다제 및 ｌｏｘｌ２로부터의 촉매 도메인
AU2010286111A1 (en) 2009-08-21 2012-02-16 Beeologics Inc. Preventing and curing beneficial insect diseases via plant transcribed molecules
AU2010284000A1 (en) * 2009-08-21 2012-03-22 Gilead Biologics, Inc. In vitro screening assays
US9642817B2 (en) 2009-08-27 2017-05-09 Technion Research & Development Foundation Limited Liposomal compositions and uses of same
WO2011030332A2 (fr) 2009-09-08 2011-03-17 Yeda Research And Development Co. Ltd. Procédés pour la mobilisation de précurseur hématopoïétique
EP2475784A1 (fr) 2009-09-08 2012-07-18 Ramot at Tel-Aviv University Ltd. Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
WO2011030329A1 (fr) 2009-09-10 2011-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthode de traitement de tumeurs
WO2011034950A1 (fr) 2009-09-16 2011-03-24 Vaxart, Inc. Stratégie d'immunisation pour empêcher une infection par le h1n1
WO2011033506A2 (fr) 2009-09-17 2011-03-24 Yeda Research And Development Co. Ltd. Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
US8735124B2 (en) 2009-09-17 2014-05-27 Yeda Research And Development Co. Ltd. Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
EP2478009B1 (fr) 2009-09-17 2016-06-01 Ramot at Tel-Aviv University Ltd. Peptides pour le traitement de troubles liés au stress oxydatif
CA2775092A1 (fr) 2009-09-23 2011-03-31 Protiva Biotherapeutics, Inc. Compositions et procedes pour reduire au silence des genes exprimes dans le cancer
US20110081706A1 (en) * 2009-10-02 2011-04-07 TransAlgae Ltd Method and system for efficient harvesting of microalgae and cyanobacteria
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
WO2011045796A1 (fr) 2009-10-14 2011-04-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions pour lutter contre les acariens varroa chez l'abeille
ES2609006T3 (es) 2009-10-16 2017-04-18 Rutgers, The State University Of New Jersey Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
US9476060B2 (en) 2009-10-21 2016-10-25 Danziger Innovations Ltd. Generating genotypic variations in plant genomes by gamete infection
IL201999A (en) 2009-11-08 2017-10-31 Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
EP2498806B1 (fr) 2009-11-12 2014-12-31 Ramot at Tel-Aviv University Ltd. Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
EP3633025B1 (fr) 2009-11-12 2022-09-14 Technion Research & Development Foundation Ltd. Milieu de culture, cultures de cellules et procédés de culture de cellules souches pluripotentes dans un état indifférencié
WO2011058555A1 (fr) 2009-11-12 2011-05-19 Yeda Research And Development Co. Ltd. Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
WO2011061736A1 (fr) 2009-11-17 2011-05-26 Protalix Ltd. Alpha galactosidase alcaline pour le traitement de la maladie de fabry
EP2504472A1 (fr) 2009-11-24 2012-10-03 Collplant Ltd. Procédé de production de fibres de collagène
IL288647B2 (en) 2009-11-30 2023-12-01 Pluri Biotech Ltd Adherent cells of placental origin and their use for the treatment of heart failure
WO2011067745A2 (fr) 2009-12-06 2011-06-09 Rosetta Green Ltd. Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
EP2510098B1 (fr) 2009-12-09 2015-02-11 Quark Pharmaceuticals, Inc. Méthodes et compositions utilisées pour le traitement de maladies, d'affections ou de lésions du snc
US9493785B2 (en) 2009-12-28 2016-11-15 Evogene Ltd. Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
EP3785712A1 (fr) 2009-12-29 2021-03-03 Gamida-Cell Ltd. Procédés de renforcement de la prolifération et de l'activité de cellules tueuses naturelles
DK2521776T3 (en) 2010-01-05 2017-02-13 Vascular Biogenics Ltd METHODS FOR USING A SPECIFIC ANTI-ANGIOGENT ADENOVIRAL AGENT
WO2011086509A1 (fr) 2010-01-12 2011-07-21 Vascular Biogenics Ltd. Procédés de production de vecteurs adénoviraux et préparations virales générées par ce biais
EP2528949A1 (fr) 2010-01-27 2012-12-05 Yeda Research And Development Co. Ltd. Anticorps inhibant les métalloprotéines
JP6134142B2 (ja) 2010-02-04 2017-05-24 ギリアド バイオロジクス, インク.Gilead Biologics, Inc. リシルオキシダーゼ様２（ｌｏｘｌ２）に結合する抗体及びその使用方法
WO2011099006A2 (fr) 2010-02-11 2011-08-18 Yeda Research And Development Co. Ltd. Systèmes enzymatiques pour la fixation du carbone et procédés de production associés
CA2791058A1 (fr) 2010-02-24 2011-09-01 Ben Gurion University Of The Negev Research And Development Authority Methodes d'inhibition de la necrose
WO2011107939A1 (fr) 2010-03-01 2011-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
WO2011107994A1 (fr) 2010-03-04 2011-09-09 Yeda Research And Development Co. Ltd. Procédés de mesure de la stabilité d'une protéine
KR101982126B1 (ko) 2010-03-08 2019-05-27 몬산토 테크놀로지 엘엘씨 식물에서 유전자 조절을 위한 폴리뉴클레오타이드 분자
EP2545176B1 (fr) 2010-03-08 2016-05-11 Yeda Research and Development Co. Ltd. Production de protéines recombinantes dans des systèmes hétérologues
US20120329089A1 (en) 2010-03-11 2012-12-27 Jacob Edrei Methods of generating hydrogen
US9073990B2 (en) 2010-04-05 2015-07-07 Bar-Llan University Protease-activatable pore-forming polypeptides
EP2557913B1 (fr) 2010-04-12 2016-08-03 Ben Gurion University Of The Negev Research And Development Authority Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
WO2011128897A1 (fr) 2010-04-12 2011-10-20 Technion Research & Development Foundation Ltd. Population de cellules progénitrices pancréatiques et leurs méthodes d'isolement et d'utilisation
RU2012148398A (ru) 2010-04-18 2014-05-27 Иеда Рисеч Энд Девелопмент Ко. Лтд. МОЛЕКУЛЫ И СПОСОБЫ ПРИМЕНЕНИЯ МОЛЕКУЛ ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНЕЙ, АССОЦИИРОВАННЫХ С ErbB/ErbB ЛИГАНДАМИ
BR122021002337B1 (pt) 2010-04-28 2022-03-22 Evogene Ltd Método de aumento de produção, biomassa, taxa de crescimento, vigor, teor de óleo, produção de fibra qualidade de fibra, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e construto de ácido nucleico isolado
US20130053277A1 (en) 2010-05-04 2013-02-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods of identifying inhibitors of polypeptides-of-interest
US9352000B2 (en) 2010-05-05 2016-05-31 Rappaport Family Institute For Research In The Medical Sciences Use of CCL1 in therapy
IL208820A0 (en) 2010-10-19 2011-01-31 Rachel Teitelbaum Biologic female contraceptives
CA2799307C (fr) 2010-05-13 2019-07-02 Tel Hashomer Medical Research Infrastructure And Services Ltd. Populations isolees de cellules renales adultes et procedes d'isolement et d'utilisation desdites populations
EP2575859B1 (fr) 2010-06-03 2018-09-19 Ramot at Tel Aviv University, Ltd. Méthodes pour le traitement du diabéte et compositions aptes à ce traitement
EP2576829A1 (fr) 2010-06-07 2013-04-10 Osnat Ashur-Fabian Méthodes et trousses pour le diagnostic d'états pathologiques associés à l'hypoxie
BR112012032126A2 (pt) 2010-06-16 2017-10-17 Futuragene Israel Ltd Empresa Isralense polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
WO2011158243A2 (fr) 2010-06-16 2011-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de diagnostic et de traitement du cancer
US9512188B2 (en) 2010-07-12 2016-12-06 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Isolated polynucleotides and methods and plants using same for regulating plant acidity
JP2013535963A (ja) 2010-07-15 2013-09-19 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド Ｍｈｃクラスｉｉと糖尿病関連自己抗原性ペプチドとの天然型複合体に対するｔ細胞受容体様特異性を有する単離された高親和性実体
EP2593554A2 (fr) 2010-07-15 2013-05-22 Technion Research And Development Foundation Ltd. Construction d'acide nucléique destinée à accroître la tolérance au stress abiotique dans des végétaux
WO2012007951A1 (fr) 2010-07-15 2012-01-19 Technion Research & Development Foundation Ltd. Entités isolées à affinité élevée dotées d'une spécificité telle que celle des récepteurs de lymphocytes t pour des complexes natifs du cmh de classe ii et peptides auto-antigènes de la décarboxylase de l'acide glutamique (gad)
US9624469B2 (en) 2010-07-22 2017-04-18 Cellect Biotherapeutics Ltd. Regulatory immune cells with enhanced targeted cell death effect
US20130130311A1 (en) 2010-07-27 2013-05-23 Yeda Research And Development Co., Ltd. Methods and systems for assessing clonality of cell cultures
JP2013535966A (ja) 2010-07-27 2013-09-19 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド 引き抜かれた毛包由来のケラチン生成細胞から誘導多能性幹細胞を生成させる方法
WO2012014205A1 (fr) 2010-07-27 2012-02-02 Technion Research & Development Foundation Ltd. Cellules progénitrices mésenchymateuses isolées et matrice extra-cellulaire produite au moyen de celles-ci
EP2600885A2 (fr) 2010-08-04 2013-06-12 Ramot at Tel Aviv University, Ltd. Procédés de traitement de maladies auto-immunes du système nerveux central (snc) et de maladies neurodégénératives
SG187830A1 (en) 2010-08-22 2013-03-28 Univ Ramot Induced pluripotent stem cells derived from human pancreatic beta cells
WO2012025925A1 (fr) 2010-08-24 2012-03-01 Rappaport Family Institute For Research In The Medical Sciences Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
AR082530A1 (es) 2010-08-30 2012-12-12 Evogene Ltd Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico
WO2012032510A1 (fr) 2010-09-07 2012-03-15 Yeda Research And Development Co. Ltd. Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
WO2012032520A1 (fr) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
WO2012032519A2 (fr) 2010-09-07 2012-03-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthodes de diagnostic de la maladie de parkinson
EP3572501A1 (fr) 2010-09-07 2019-11-27 Technion Research & Development Foundation Limited Nouveaux procédés et milieux de culture destinés à la culture de cellules souches pluripotentes
SG188473A1 (en) 2010-09-08 2013-05-31 Yeda Res & Dev Use of anti third party central memory t cells for anti-leukemia/lymphoma treatment
JP2013540731A (ja) 2010-09-08 2013-11-07 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 安定かつ長期間の生着のための免疫抑制薬物組合せ
EP2616539A1 (fr) 2010-09-15 2013-07-24 Ramot at Tel-Aviv University Ltd. Procédés d'expansion et de redifférenciation de cellules bêta des îlots
WO2012038956A1 (fr) 2010-09-20 2012-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de traitement de maladies neurodégénératives
EP3075396A1 (fr) 2010-10-17 2016-10-05 Yeda Research and Development Co. Ltd. Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
WO2012052878A1 (fr) 2010-10-19 2012-04-26 Vascular Biogenics Ltd. Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
WO2012056452A2 (fr) 2010-10-27 2012-05-03 Nanocyte (Israel) Ltd. Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
WO2012056455A1 (fr) 2010-10-28 2012-05-03 Yeda Research And Development Co. Ltd. Procédés de génération d'anticorps anti-métalloenzymes
CA2815927A1 (fr) 2010-11-03 2012-05-10 Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. Plantes transgeniques a rendements de saccharification ameliores, et procede pour les generer
US9410132B2 (en) 2010-11-04 2016-08-09 Ben-Gurion University Of The Negev Research And Development Authority Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
AR083885A1 (es) 2010-11-15 2013-03-27 Univ Ramot Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides
WO2012066495A2 (fr) 2010-11-17 2012-05-24 Ben Gurion University Of The Negev Research And Development Authority Thérapie à base de cellules t pour les maladies neurodégénératives
US9574171B2 (en) 2010-12-02 2017-02-21 Technion Research & Development Foundation Ltd. Methods of generating corneal cells and cell populations comprising same
US20120183960A1 (en) 2010-12-07 2012-07-19 Enterologics, Inc. Method for identifying e. coli m-17
WO2012081029A1 (fr) 2010-12-15 2012-06-21 Kadimastem Ltd. Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
BR122021002251B1 (pt) 2010-12-22 2021-09-14 Evogene Ltd Método para aumentar a tolerância ao estresse abiótico, rendimento, biomassa, taxa de crescimento, vigor, conteúdo de óleo, rendimento de fibras, qualidade de fibras e/ou eficiência de utilização de nitrogênio de uma planta, e, construção de ácido nucleico isolado
AU2011350620B2 (en) 2010-12-28 2017-03-02 Kamedis Ltd. Plant extracts for the treatment and prevention of infections
LT3272861T (lt) 2011-01-20 2020-03-25 Protalix Ltd. Alfa-galaktozidazės kompozicijos
US20130316358A1 (en) 2011-01-31 2013-11-28 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
WO2012114339A1 (fr) 2011-02-23 2012-08-30 Rappaport Family Institute For Research In The Medical Sciences Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
RU2640246C2 (ru) 2011-03-02 2017-12-27 Футураджен Израиль Лтд. Устойчивые к бактериям трансгенные растения
EP2680864B1 (fr) 2011-03-03 2019-05-08 Ramot at Tel-Aviv University Ltd. Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
AU2012226398B9 (en) 2011-03-06 2017-04-13 Merck Serono S.A. Low fucose cell lines and uses thereof
WO2012120518A1 (fr) 2011-03-08 2012-09-13 Ramot At Tel-Aviv University Ltd. Compositions et méthodes de diagnostic et de traitement de phénylcétonurie (pcu)
US20140086839A1 (en) 2011-03-17 2014-03-27 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
MX342135B (es) 2011-03-17 2016-09-14 Ramot At Tel-Aviv Univ Ltd Anticuerpos asimetricos, biespecificos y monoespecificos, y metodos para generar los mismos.
KR101835917B1 (ko) 2011-03-22 2018-03-07 플루리스템 리미티드 방사선 또는 화학적 손상을 치료하는 방법들
JP5960793B2 (ja) 2011-03-24 2016-08-02 ニューリム ファーマシューティカルズ（１９９１）リミテッド 神経保護ペプチド
WO2012131680A2 (fr) 2011-03-28 2012-10-04 Yeda Research And Development Co. Ltd. Compositions et procédés pour le traitement de l'inflammation
WO2012137202A1 (fr) 2011-04-05 2012-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
CA2832031C (fr) 2011-04-06 2019-09-17 Ramot At Tel-Aviv University Ltd. Procedes de controle et d'analyse du diagnostic de profils d'activite metabolique et utilisations therapeutiques desdits procedes
US9150644B2 (en) 2011-04-12 2015-10-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
ES2768296T3 (es) 2011-04-15 2020-06-22 Pluristem Ltd Métodos y sistemas para recoger células
CA3139245A1 (fr) 2011-05-03 2012-11-08 Evogene Ltd. Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement de plantes, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique de plantes et l'efficacite d'utilisation de l'azote
WO2012150600A2 (fr) 2011-05-04 2012-11-08 Ramot At Tel-Aviv University Ltd. Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
WO2012153333A1 (fr) 2011-05-09 2012-11-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
WO2012153336A2 (fr) 2011-05-12 2012-11-15 Rakuto Bio Technologies Ltd. Procédés et dispositifs pour éclaircir la carnation de la peau
WO2012156976A1 (fr) 2011-05-16 2012-11-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
WO2012160526A2 (fr) 2011-05-23 2012-11-29 Ofir Menashe Formulations à base de particules contenant des micro-organismes et leurs utilisations
EP3263127B1 (fr) 2011-05-23 2019-08-21 Yeda Research and Development Co. Ltd Utilisation de la phosphorylation akt en tant que biomarqueur de pronostic de maladies neurodégénératives et le traitement de ceux-ci
US9284351B2 (en) 2011-05-31 2016-03-15 Hutchison Biofilm Medical Solutions Ltd. Dispersion and detachment of cell aggregates
US20140113376A1 (en) 2011-06-01 2014-04-24 Rotem Sorek Compositions and methods for downregulating prokaryotic genes
US10166295B2 (en) 2011-06-02 2019-01-01 Opko Biologics Ltd. Pegylated OXM variants
ES2670596T3 (es) 2011-06-14 2018-05-31 Yeda Research And Development Co. Ltd. Terapia de combinación para prevenir la formación del DCIS y la progresión hasta cáncer de mama
US20140130199A1 (en) 2011-06-23 2014-05-08 Kaiima Bio Agritech Ltd. Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
AR087220A1 (es) 2011-07-20 2014-02-26 Kaiima Bio Agritech Ltd Plantas de maiz que tienen un genoma parcial o completamente multiplicado y sus usos
EP2550982A1 (fr) 2011-07-27 2013-01-30 Technion Research & Development Foundation Ltd. Dispositifs pour applications chirurgicales
WO2013018060A2 (fr) 2011-08-04 2013-02-07 Yeda Research And Development Co. Ltd. Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles médicaux associés à la sérotonine, à l'adrénaline, à la noradrénaline, au glutamate et à l'hormone de libération de la corticotropine
WO2013021389A2 (fr) 2011-08-09 2013-02-14 Yeda Research And Development Co.Ltd. Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
WO2013024481A1 (fr) 2011-08-14 2013-02-21 Kaiima Bio Agritech Ltd. Plantes de blé dur ayant un génome partiellement ou complètement multiplié, et leurs utilisations
EP2753367A4 (fr) 2011-09-07 2015-10-14 Yeda Res & Dev Signature olfactive et mélange odorant la contenant
ES2640813T3 (es) 2011-09-08 2017-11-06 Yeda Research And Development Co. Ltd. Linfocitos T de memoria central antiterceros, métodos para producirlos y uso de los mismos en un trasplante y el tratamiento de enfermedades
US20140248293A1 (en) 2011-09-08 2014-09-04 Yeda Research And Development Co., Ltd Novel risk biomarkers for lung cancer
MX343072B (es) 2011-09-13 2016-10-21 Monsanto Technology Llc Metodos y composiciones para controlar malezas.
US10806146B2 (en) 2011-09-13 2020-10-20 Monsanto Technology Llc Methods and compositions for weed control
MX343071B (es) 2011-09-13 2016-10-21 Monsanto Technology Llc Metodos y composiciones para el control de malezas.
US10760086B2 (en) 2011-09-13 2020-09-01 Monsanto Technology Llc Methods and compositions for weed control
US10829828B2 (en) 2011-09-13 2020-11-10 Monsanto Technology Llc Methods and compositions for weed control
ES2645927T3 (es) 2011-09-13 2017-12-11 Monsanto Technology Llc Procedimientos y composiciones para el control de malezas
BR112014005975A8 (pt) 2011-09-13 2017-09-12 Monsanto Technology Llc Método de controle de planta, método de redução de expressão de um gene pds em uma planta, cassete de expressão microbiana, método de fazer um polinucleotídeo, método de identificação de polinucleotídeos, e composições para controle de erva daninha
WO2013054320A1 (fr) 2011-10-11 2013-04-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
CA2852758C (fr) 2011-10-21 2020-12-29 Augurex Life Sciences Corporation Antigenes derives de peptides 14-3-3 citrullines et utilisations de ceux-ci dans le diagnostic de polyarthrite rhumatoide
WO2013061328A2 (fr) 2011-10-27 2013-05-02 Yeda Research And Development Co. Ltd. Procédé de traitement du cancer
AU2012332517B9 (en) 2011-11-03 2017-08-10 Quark Pharmaceuticals, Inc. Methods and compositions for neuroprotection
EP2776565A1 (fr) 2011-11-08 2014-09-17 Quark Pharmaceuticals, Inc. Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
US9736998B2 (en) 2011-11-23 2017-08-22 Danziger Dan Flower Farm Otomeria plants
EP2782930B1 (fr) 2011-11-27 2018-07-11 Yeda Research and Development Co. Ltd. Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
JP2015500279A (ja) 2011-12-08 2015-01-05 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 哺乳動物胎児肺細胞および該細胞の治療的使用
WO2013093921A1 (fr) 2011-12-20 2013-06-27 Collplant Ltd. Fibres de polymère synthétique enrobées de collagène
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
US20130164193A1 (en) 2011-12-22 2013-06-27 Life Technologies Corporation Sequential lateral flow capillary device for analyte determination
ES2811529T3 (es) 2011-12-22 2021-03-12 Yeda Res & Dev Una terapia de combinación para un injerto estable y a largo plazo usando protocolos específicos para el agotamiento de los linfocitos T/B
EP2797405A1 (fr) 2011-12-28 2014-11-05 Kaiima Bio Agritech Ltd. Sorgho agricole à génome partiellement ou complètement multiplié, et utilisations correspondantes
CN104080480A (zh) 2012-01-01 2014-10-01 奇比艾企业有限公司 用于选择性递送治疗剂和诊断剂的endo180靶向微粒
WO2013114363A2 (fr) 2012-01-30 2013-08-08 Yeda Research And Development Co.Ltd. Agents antimicrobiens
WO2013114373A1 (fr) 2012-02-01 2013-08-08 Protalix Ltd. Formulations liquides inhalables d'adnase i
WO2013118120A2 (fr) 2012-02-06 2013-08-15 Rosetta Green Ltd. Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
SG11201404608WA (en) 2012-02-13 2014-09-26 Gamida Cell Ltd Mesenchymal stem cells conditioned medium and methods of generating and using the same
HUE053068T2 (hu) 2012-02-14 2021-06-28 Opko Biologics Ltd Hosszú hatástartamú koagulációs faktorok és alkalmazásaik
IN2014MN01806A (fr) 2012-02-19 2015-07-03 Protalix Ltd
EP2844745A2 (fr) 2012-02-22 2015-03-11 Brainstem Biotec Ltd. Génération de cellules souches neuronales et de motoneurones
JP6329911B2 (ja) 2012-02-22 2018-05-23 ブレインステム バイオテック リミテッド 星状膠細胞作製のためのミクロｒｎａ
KR20220045089A (ko) 2012-02-24 2022-04-12 아뷰터스 바이오파마 코포레이션 트리알킬 양이온성 지질 및 그의 사용 방법
US20150101074A1 (en) 2012-03-01 2015-04-09 The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
ES2691931T3 (es) 2012-03-07 2018-11-29 Yeda Research And Development Co. Ltd. Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
US9334308B2 (en) 2012-03-22 2016-05-10 Ramot At Tel-Aviv University Ltd. PLIF multimeric peptides and uses thereof
WO2013156989A1 (fr) 2012-04-18 2013-10-24 Ramot At Tel-Aviv University Ltd. Particules de glycosaminoglycane lipidé pour la libération d'acides nucléiques
CN104487082A (zh) 2012-04-19 2015-04-01 奥普科生物制品有限公司 长效胃泌酸调节素变体及其生产方法
WO2013160895A1 (fr) 2012-04-24 2013-10-31 Biokine Therapeutics Ltd. Peptides et leur utilisation dans le traitement du cancer du poumon à grandes cellules
EP2846819B1 (fr) 2012-05-09 2017-05-03 Yeda Research and Development Co. Ltd. Variants de pro-domaine tace en tant qu'inhibiteur de tnf-a et leur utilisation médicale
US10240161B2 (en) 2012-05-24 2019-03-26 A.B. Seeds Ltd. Compositions and methods for silencing gene expression
IN2014KN02831A (fr) 2012-05-24 2015-05-08 Mountgate Group Ltd
US9731048B2 (en) 2012-06-03 2017-08-15 Ben-Gurion University Of The Negev Research And Development Authority Functionalized titanium binding peptides and implants coated with same
CN109096387B (zh) 2012-06-04 2021-11-30 奥普科生物制品有限公司 聚乙二醇化的oxm变体
EP2870110A1 (fr) 2012-07-03 2015-05-13 Nanospun Technologies Ltd. Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
WO2014018375A1 (fr) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 et ses utilisations dans des méthodes thérapeutiques et diagnostiques
EP2880155B1 (fr) 2012-07-29 2019-04-17 Yeda Research and Development Co., Ltd. Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
JP6340366B2 (ja) 2012-07-31 2018-06-06 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 運動ニューロン疾患を診断および処置する方法
ES2813407T3 (es) 2012-08-06 2021-03-23 Brainstorm Cell Therapeutics Ltd Métodos para generar células madre mesenquimales que secretan factores neurotróficos
US20140068814A1 (en) 2012-09-03 2014-03-06 A.B. Seeds Ltd. Method of improving abiotic stress tolerance of plants and plants generated thereby
EP2895197B1 (fr) 2012-09-12 2020-02-26 Ramot at Tel-Aviv University Ltd. Immunoparticules, méthodes pour leur préparation, et leur utilisation
WO2014057490A1 (fr) 2012-10-09 2014-04-17 Ramot At Tel-Aviv University Ltd. Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
AU2013336237A1 (en) 2012-10-22 2015-06-11 Sabag-Rfa Ltd A system for delivering therapeutic agents into living cells and cells nuclei
WO2014064682A1 (fr) 2012-10-24 2014-05-01 Yeda Research And Development Co. Ltd. Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
WO2014068553A1 (fr) 2012-10-29 2014-05-08 Yeda Research And Development Co. Ltd. Aptamères, aptamères multimères et leurs utilisations
BR122020018510B1 (pt) 2012-11-20 2023-03-14 Opko Biologics Ltd Método para aumentar incrementalmente o tamanho hidrodinâmico de um fator de coagulação ativado viia
WO2015079413A2 (fr) 2013-11-28 2015-06-04 Yeda Research And Development Co. Ltd. Inhibiteurs de synaptojanine-2 et leurs utilisations
BR112015002626A2 (pt) 2012-11-29 2017-09-26 Yeda Res & Dev métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
US10683505B2 (en) 2013-01-01 2020-06-16 Monsanto Technology Llc Methods of introducing dsRNA to plant seeds for modulating gene expression
US10041068B2 (en) 2013-01-01 2018-08-07 A. B. Seeds Ltd. Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
WO2014108850A2 (fr) 2013-01-09 2014-07-17 Yeda Research And Development Co. Ltd. Analyse de transcriptome à haut débit
WO2014108854A1 (fr) 2013-01-09 2014-07-17 Fusimab Ltd. Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
CA2894472C (fr) 2013-01-17 2021-08-17 Novellusdx Ltd. Procedes et systemes pour identifier des mutations conductrices specifiques a un patient
WO2014118785A1 (fr) 2013-02-04 2014-08-07 Ramot At Tel-Aviv University Ltd. Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
US20160017020A1 (en) 2013-03-06 2016-01-21 Protalix Ltd. Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
JP6622591B2 (ja) 2013-03-06 2019-12-18 プロタリクス リミテッド ＴＮＦαポリペプチド阻害薬を発現する植物細胞の、治療法における使用
AU2014248958A1 (en) 2013-03-13 2015-10-01 Monsanto Technology Llc Methods and compositions for weed control
EP2971185A4 (fr) 2013-03-13 2017-03-08 Monsanto Technology LLC Procédés et compositions utilisables pour lutter contre les mauvaises herbes
US10568328B2 (en) 2013-03-15 2020-02-25 Monsanto Technology Llc Methods and compositions for weed control
WO2014147622A1 (fr) 2013-03-21 2014-09-25 Collplant Ltd. Compositions comprenant du collagène et prp pour la régénération tissulaire
AU2014240733B2 (en) 2013-03-24 2018-11-22 Biolinerx Ltd. Methods of treating myeloid leukemia
CA2909380A1 (fr) 2013-04-21 2014-10-30 Yeda Research And Development Co. Ltd. Agents de regulation a la baisse de l'activite et/ou de la quantite de bcl-xl et/ou bcl-w
WO2014174470A1 (fr) 2013-04-23 2014-10-30 Yeda Research And Development Co. Ltd. Cellules souches pluripotentes naïves isolées et leurs procédés de génération
US9714268B2 (en) 2013-04-25 2017-07-25 Yeda Research And Development Co. Ltd. Use of inhibitory peptides for the treatment of inflammatory diseases
US20160115231A1 (en) 2013-05-21 2016-04-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Treatment of mast cell related pathologies
ES2771048T3 (es) 2013-05-27 2020-07-06 Rakuto Bio Tech Ltd Composiciones cosméticas que contienen sistemas enzimáticos
ES2938044T3 (es) 2013-06-24 2023-04-04 Univ Ramot Estructura a base de epiplón y sistema de suministro
US9850496B2 (en) 2013-07-19 2017-12-26 Monsanto Technology Llc Compositions and methods for controlling Leptinotarsa
CN105980567B (zh) 2013-07-19 2021-04-16 孟山都技术有限公司 用于控制叶甲属的组合物和方法
WO2015015489A1 (fr) 2013-07-30 2015-02-05 Biolinerx Ltd. Anticorps convenant au traitement du diabète et de maladies autoimmunes
US9938316B2 (en) 2013-08-29 2018-04-10 Yeda Research And Development Co. Ltd. Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
IL228284A (en) 2013-09-03 2016-12-29 Technion Res & Dev Foundation Implants from cellular scaffolding and blood vessel stalk
US20160251410A1 (en) 2013-09-03 2016-09-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for expressing recombinant polypeptides
WO2015033344A1 (fr) 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
WO2015037009A1 (fr) 2013-09-16 2015-03-19 Plexicure Ltd. Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
WO2015040609A1 (fr) 2013-09-17 2015-03-26 Yeda Research And Development Co. Ltd. Nouveaux peptides d'erk et leurs utilisations
WO2015049677A1 (fr) 2013-10-01 2015-04-09 Kadimastem Ltd. Différenciation dirigée d'astrocytes à partir de cellules souches pluripotentes humaines pour utilisation dans le criblage de médicaments et le traitement de la sclérose latérale amyotrophique (sla)
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
KR102444140B1 (ko) 2013-10-21 2022-09-15 옵코 바이오로직스 리미티드 장시간-작용하는 폴리펩티드, 그의 생산 방법, 및 그의 투여 방법
US10767156B2 (en) 2013-10-24 2020-09-08 Yeda Research And Development Co., Ltd. Polynucleotides encoding BREX system polypeptides and methods of using same
AU2014343214B2 (en) 2013-10-31 2020-04-09 Biolinerx Ltd. Methods of treating acute myeloid leukemia with a FLT3 mutation
MX2016005778A (es) 2013-11-04 2016-12-20 Monsanto Technology Llc Composiciones y metodos para controlar infestaciones de plagas y parasitos de los artropodos.
WO2015079411A1 (fr) 2013-11-28 2015-06-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Inhibiteurs de l'arn polymérase i et leurs utilisations
UA119253C2 (uk) 2013-12-10 2019-05-27 Біолоджикс, Інк. Спосіб боротьби із вірусом у кліща varroa та у бджіл
EP3080243B1 (fr) 2013-12-10 2018-09-05 Yeda Research and Development Co., Ltd. Utilisation d'enzymes catalysant la synthèse de pyruvate à partir de formiate et d'acétyl-coa et bactéries les exprimant
CN105979770B (zh) 2014-01-15 2019-07-05 孟山都技术公司 用于使用epsps多核苷酸的杂草控制的方法和组合物
US20160340659A1 (en) 2014-01-30 2016-11-24 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
JP2017506259A (ja) 2014-02-03 2017-03-02 イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドＹｉｓｓｕｍ Ｒｅｓｅａｒｃｈ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏｍｐａｎｙ Ｏｆ Ｔｈｅ Ｈｅｂｒｅｗ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｊｅｒｕｓａｌｅｍ Ｌｔｄ． 幹細胞を枯渇させるためのカゼインキナーゼｉ阻害剤の使用
WO2015118537A2 (fr) 2014-02-05 2015-08-13 Yeda Research And Development Co. Ltd. Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles médicaux associés à la sérotonine, à l'adrénaline, à la noradrénaline, au glutamate et à l'hormone de libération de la corticotropine
CN106573976B (zh) 2014-02-06 2020-05-05 耶达研究及发展有限公司 抗cd84抗体、包含所述抗体的组合物及其用途
WO2015118547A1 (fr) 2014-02-10 2015-08-13 Protalix Ltd. Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
BR112016018489A2 (pt) 2014-02-11 2017-08-08 Brainstorm Cell Therapeutics Ltd Método de qualificação de células, população isolada de células-tronco mesenquimais, método de tratamento de uma doença imune ou inflamatória, e uso de células-tronco mesenquimais
WO2015132784A1 (fr) 2014-03-03 2015-09-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé et dispositif de détection de pseudomonas aeruginosa
EP2923709A1 (fr) 2014-03-28 2015-09-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vaccin contre la malaria multi-composants-multi-étapes
WO2015153339A2 (fr) 2014-04-01 2015-10-08 Monsanto Technology Llc Compositions et procédés pour lutter contre les insectes nuisibles
WO2015155777A1 (fr) 2014-04-10 2015-10-15 Bonus Therapeutics Ltd. Compositions pour la réparation des os
EP3643795B1 (fr) 2014-04-14 2022-03-30 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Procédé de détermination de mort de cellules ou de tissues par analyse de methylation de l'adn
US10590467B2 (en) 2014-04-17 2020-03-17 Yeda Research And Development Co. Ltd. Methods and kits for analyzing DNA binding moieties attached to DNA
MX366359B (es) 2014-04-27 2019-07-05 Ccam Biotherapeutics Ltd Anticuerpos humanizados contra la molecula de adhesion celular relacionada al antigeno carcinoembrionico 1 (ceacam1).
US11427647B2 (en) 2014-04-27 2022-08-30 Famewave Ltd. Polynucleotides encoding humanized antibodies against CEACAM1
WO2015166492A2 (fr) 2014-04-28 2015-11-05 Yeda Research And Development Co. Ltd. Réponse du microbiome à des agents
MX2016014128A (es) 2014-05-04 2017-05-23 Forrest Innovations Ltd Composiciones y procedimientos para recudir el enverdecimiento de los citricos inducido por patogenos.
WO2015177800A2 (fr) 2014-05-22 2015-11-26 Yeda Research And Development Co. Ltd. Micro-organismes recombinés pouvant fixer le carbone
EP3149155B1 (fr) 2014-06-02 2020-09-23 Kadimastem Ltd. Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
WO2015186129A1 (fr) 2014-06-02 2015-12-10 Technion Research & Development Foundation Limited. Compositions et procédés d'inhibition sélective d'irp1 et traitement de l'inflammation
AU2015280252A1 (en) 2014-06-23 2017-01-12 Monsanto Technology Llc Compositions and methods for regulating gene expression via RNA interference
EP3145951A1 (fr) 2014-06-24 2017-03-29 InSight Biopharmaceuticals Ltd. Procédés de purification d'anticorps
EP3161138A4 (fr) 2014-06-25 2017-12-06 Monsanto Technology LLC Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
SG11201610630RA (en) 2014-06-25 2017-01-27 Tel Hashomer Medical Res Infrastructure & Services Ltd Identification of cancer stem cell markers and use of same for diagnosis and treatment
US10583084B2 (en) 2014-06-26 2020-03-10 Ramot At Tel-Aviv University Ltd. Liposomal formulations for delivery of nucleic acids
WO2016005985A2 (fr) 2014-07-09 2016-01-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Méthode pour reprogrammer des cellules
CN107001442B (zh) 2014-07-15 2021-04-27 耶路撒冷希伯来大学伊森姆研究发展公司 Cd44的分离的多肽及其应用
CA2955414A1 (fr) 2014-07-21 2016-01-28 Novellusdx Ltd. Procedes et systemes pour determiner un indice oncogenique de mutations specifiques d'un patient
CA2955411A1 (fr) 2014-07-21 2016-01-28 Novellusdx Ltd. Procedes de determination d'une reponse a un medicament de mutations specifiques a un patient
US10378012B2 (en) 2014-07-29 2019-08-13 Monsanto Technology Llc Compositions and methods for controlling insect pests
CN108064274A (zh) 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
CN111624346A (zh) 2014-08-14 2020-09-04 米密德诊断学有限公司 用于预测及/或决定预后的套组
WO2016030899A1 (fr) 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Méthodes de traitement de la sclérose latérale amyotrophique
EP3191523B1 (fr) 2014-09-08 2019-08-07 Yeda Research and Development Co., Ltd. Compositions et procédés de traitement d'un cancer résistant à un inhibiteur de la tyrosine kinase (tki)
EP2992895A1 (fr) 2014-09-08 2016-03-09 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vaccin contre la malaria multi-composants-multi-étapes
CA2959716A1 (fr) 2014-09-08 2016-03-17 Yeda Research And Development Co. Ltd. Anticorps anti-her3 et leurs utilisations
IL234638A0 (en) 2014-09-14 2014-12-02 Yeda Res & Dev NMDA receptor antagonists for the treatment of Gaucher disease
WO2016042561A2 (fr) 2014-09-21 2016-03-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Freination du mir-132 pour le traitement de troubles lipidiques
DE102015220401B4 (de) 2014-10-20 2022-12-29 Gen-Probe Incorporated Erythrozyten-Lyselösung
AU2015346969B2 (en) 2014-11-13 2019-03-21 Enzootic Holdings Ltd. Functional sex-reversal of decapod crustacean females
CA2967233A1 (fr) 2014-11-17 2016-05-26 Yeda Research And Development Co. Ltd. Procede d'analyse de microbiome
WO2016079736A2 (fr) 2014-11-17 2016-05-26 Yeda Research And Development Co. Ltd. Procédés de traitement de maladies associées à une fonction mitochondriale
BR112017010268B1 (pt) 2014-11-19 2024-01-16 P & M Venge Ab Agente de ligação, composição de diagnóstico, kit de diagnóstico, método de diagnóstico de uma infecção bacteriana ou de diferenciação entre uma infecção bacteriana e uma infecção de viral, métodos para descartar uma infecção bacteriana ou viral em um indivíduo, métodos para considerar uma infecção bacteriana ou viral em um indivíduo, método para distinguir entre uma infecção bacteriana ou mista e uma infecção viral em um indivíduo, método para descartar uma doença infecciosa, método para identificação do tipo de infecção e dispositivo para o diagnóstico de infecções bacterianas
EP3221455B1 (fr) 2014-11-20 2020-08-12 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
CN107208070B (zh) 2014-11-26 2021-09-07 技术创新动力基金（以色列）有限合伙公司 细菌基因的靶向消除
CA2968808A1 (fr) 2014-11-27 2016-06-02 Danziger Innovations Ltd. Construction d'acide nucleique pour l'edition de genome
WO2016092555A2 (fr) 2014-12-11 2016-06-16 Yeda Research And Development Co. Ltd. Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
WO2016103269A1 (fr) 2014-12-23 2016-06-30 Ramot At Tel-Aviv University Ltd. Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
KR102514912B1 (ko) 2014-12-30 2023-03-27 셀 큐어 뉴로사이언시스 리미티드 망막 질환의 치료 방법
ES2880346T3 (es) 2014-12-30 2021-11-24 Cell Cure Neurosciences Ltd Evaluación de poblaciones de células epiteliales de pigmento retiniano
ES2774456T3 (es) 2014-12-30 2020-07-21 Cell Cure Neurosciences Ltd Poblaciones de células del RPE y métodos de generación de las mismas
WO2016108244A1 (fr) 2015-01-04 2016-07-07 Protalix Ltd. Dnase modifiée et ses utilisations
WO2016116935A1 (fr) 2015-01-21 2016-07-28 Yeda Research And Development Co. Ltd. Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
JP6942632B2 (ja) 2015-01-22 2021-09-29 モンサント テクノロジー エルエルシー Ｌｅｐｔｉｎｏｔａｒｓａ防除用組成物及びその方法
EP3261612A1 (fr) 2015-02-26 2018-01-03 Yeda Research and Development Co. Ltd Procédé favorisant la pousse des cheveux
US10781445B2 (en) 2015-03-11 2020-09-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Decoy oligonucleotides for the treatment of diseases
IL237852A0 (en) 2015-03-19 2016-03-24 Yeda Res & Dev Antibodies against amphigoline, medical preparations containing them and their use
AU2016243124A1 (en) 2015-03-27 2017-11-02 University Of Southern California CAR T-cell therapy directed to LHR for the treatment of solid tumors
US20180064748A1 (en) 2015-03-27 2018-03-08 Yeda Research And Development Co. Ltd. Methods of treating motor neuron diseases
BR112017021016A2 (pt) 2015-03-31 2018-07-03 Yeda Research And Development Co Ltd preparação de proteína, composição farmacêutica, proteína de fusão, polinucleotídeo isolado, estrutura de ácido nucleico, método para tratamento de doença ou condição associada ao excesso de glutamato, e método de purificação de um polipeptídeo
EP3277260B1 (fr) 2015-04-01 2021-05-12 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Extraits végétaux de crassifolium erodium l'her et leurs utilisations
EP3280401B1 (fr) 2015-04-07 2021-08-25 ELA Pharma Ltd Compositions pour le traitement et/ou la prévention de la nécrose cellulaire ou tissulaire par ciblage spécifique de cathepsine c et/ou de cela1 et/ou de cela3a et/ou des enzymes structurellement apparentées
EP3081575A1 (fr) 2015-04-12 2016-10-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Anticorps anti-plasmodium pour parasite
WO2016174674A1 (fr) 2015-04-27 2016-11-03 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Molécules de ciblage egr1 dans le traitement de maladies inflammatoires et hyperprolifératives
CN108347945B (zh) 2015-04-29 2021-03-23 以色列农业和农村发展部农业研究组织(范卡尼中心) 抗植物致病组合物
US20190031759A1 (en) 2015-04-30 2019-01-31 Technion Research & Development Foundation Limited Chimeric antigen receptors and methods of their use
WO2016178207A1 (fr) 2015-05-04 2016-11-10 Ramot At Tel-Aviv University Ltd. Procédés et kits pour fragmenter l'adn
EP3294280A1 (fr) 2015-05-11 2018-03-21 Yeda Research and Development Co., Ltd. Inhibiteurs de citrine pour le traitement du cancer
EP3298141A4 (fr) 2015-05-17 2019-01-09 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Compositions et méthodes de traitement du cancer
WO2016185457A1 (fr) 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Méthodes pour favoriser la lymphagiogenèse
WO2016185481A2 (fr) 2015-05-20 2016-11-24 Yeda Research And Development Co. Ltd. Procédé destiné à cibler des cellules sénescentes
WO2016185469A1 (fr) 2015-05-21 2016-11-24 Yeda Research And Development Co. Ltd. Populations bactériennes pour favoriser la santé
EP3302571B1 (fr) 2015-05-29 2020-11-18 OPKO Biologics Ltd. Variantes de l'oxyntomoduline pégylée
EP3302053B1 (fr) 2015-06-02 2021-03-17 Monsanto Technology LLC Compositions et procédés pour l'administration d'un polynucléotide dans une plante
EP3302030A4 (fr) 2015-06-03 2019-04-24 Monsanto Technology LLC Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
US10711064B2 (en) 2015-06-04 2020-07-14 University Of Southern California Lym-1 and Lym-2 targeted CAR cell immunotherapy
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
ES2917884T3 (es) 2015-06-18 2022-07-12 Yeda Res & Dev Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos
WO2016203476A1 (fr) 2015-06-18 2016-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
KR102172937B1 (ko) 2015-06-19 2020-11-03 옵코 바이오로직스 리미티드 장기-작용성 응고 인자 및 그의 제조 방법
US10682390B2 (en) 2015-07-16 2020-06-16 Biokine Therapeutics Ltd. Compositions and methods for treating cancer
CN114457039A (zh) 2015-07-16 2022-05-10 耶达研究及发展有限公司 基因修饰的抗第三方中央型记忆t细胞及其在免疫疗法中的用途
US10668094B2 (en) 2015-07-19 2020-06-02 Yeda Research And Development Co. Ltd. Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
BR112018001310A2 (pt) 2015-07-22 2018-09-11 Phytopharma Int Ltd composições ingeríveis por abelha, métodos de uso das mesmas para a produção de mel e mel produzido por estas
EP3328995B1 (fr) 2015-07-29 2021-03-31 Hadasit Medical Research Services And Development Production à grande échelle de cellules de l'épithélium pigmentaire rétinien
EP3331546B1 (fr) 2015-08-03 2023-10-04 Biokine Therapeutics Ltd. Antagoniste de cxcr4 pour le traitement du cancer
US20180237774A1 (en) 2015-08-04 2018-08-23 Yeda Research And Development Co. Ltd. Methods of screening for riboswitches and attenuators
EP3331995A1 (fr) 2015-08-05 2018-06-13 Cell Cure Neurosciences Ltd. Préparation de photorécepteurs pour le traitement de maladies rétiniennes
ES2932823T3 (es) 2015-08-05 2023-01-26 Cell Cure Neurosciences Ltd Preparación de células del epitelio pigmentario de la retina
EP3334449B1 (fr) 2015-08-10 2021-09-29 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
US20180237790A1 (en) 2015-08-13 2018-08-23 Forrest Innovation Ltd. Formulations and compositions for delivery of nucleic acids to plant cells
WO2017033188A1 (fr) 2015-08-24 2017-03-02 Yeda Research And Development Co. Ltd. Huile et biocarburant d'origine algale et leurs procédés de production
US10765706B2 (en) 2015-09-03 2020-09-08 University Of South Florida Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
WO2017042816A1 (fr) 2015-09-10 2017-03-16 Yeda Research And Development Co. Ltd. Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
WO2017072757A1 (fr) 2015-10-25 2017-05-04 Yeda Research And Development Co. Ltd. Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
AU2016347652A1 (en) 2015-10-26 2018-05-24 Cell Cure Neurosciences Ltd. Preparation of retinal pigment epithelium cells
JP7078538B2 (ja) 2015-10-27 2022-05-31 ジェイ ファーマ、インコーポレイティッド がんの治療のためのカンナビジオール及び第二の治療剤を含む組成物
IL242380A0 (en) 2015-10-29 2016-02-01 Yeda Res & Dev A method for inducing the division of cardiomyocytes and treating heart diseases
US20180303974A1 (en) 2015-11-03 2018-10-25 Ariel-University Research And Development Company Ltd. Compositions for regeneration and repair of neural tissue
US20180327855A1 (en) 2015-11-11 2018-11-15 Ramot At Tel-Aviv University Ltd. Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
EP3384286B1 (fr) 2015-11-30 2023-04-19 Kadimastem Ltd. Procédés de différenciation et de purification de cellules endocrines pancréatiques
EP3176183A1 (fr) 2015-12-02 2017-06-07 Yeda Research and Development Co. Ltd Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
EP4059507A1 (fr) 2015-12-16 2022-09-21 Ramot at Tel-Aviv University Ltd. Particules comprenant un omentum décellularisé
WO2017115367A1 (fr) 2015-12-28 2017-07-06 The National Institute for Biotechnology in the Negev Ltd. Composition et méthode pour le traitement de la sclérose latérale amyotrophique
CA3009127A1 (fr) 2016-01-06 2017-07-13 Yeda Research And Development Co. Ltd. Compositions et methodes pour le traitement d'affections malignes, autoimmunes et inflammatoires
WO2017122203A1 (fr) 2016-01-11 2017-07-20 Technion Research & Development Foundation Limited Méthodes de détermination du pronostic de septicémie et traitement associé
WO2017125931A1 (fr) 2016-01-21 2017-07-27 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Plantes parthénocarpiques et procédés de production de celles-ci
IL243839B (en) 2016-01-28 2018-01-31 Sp Nano Ltd Conductive wires
IL243838A (en) 2016-01-28 2017-07-31 Sp Nano Ltd The composition containing sp1 protein and carbon nanoparticles and its uses
US11261433B2 (en) 2016-01-31 2022-03-01 Hadasit Medical Research Services And Development Ltd. Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
US11230578B2 (en) 2016-02-04 2022-01-25 Yeda Research And Development Co. Ltd. Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant P53
ES2771223T3 (es) 2016-02-14 2020-07-06 Yeda Res & Dev Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
WO2017138008A2 (fr) 2016-02-14 2017-08-17 Yeda Research And Development Co. Ltd. Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
MX2018009984A (es) 2016-02-16 2019-01-21 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Análogos no proteínicos de fenilananina para la inhibicion del crecimiento de cianobacterias y plantas.
US11053476B2 (en) 2016-02-23 2021-07-06 Exostem Biotec Ltd. Generation of cancer stem cells and use thereof
EP4043492A1 (fr) 2016-03-01 2022-08-17 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Anticorps spécifiques du récepteur humain du poliovirus (rvp)
US20190085378A1 (en) 2016-03-03 2019-03-21 Memed Diagnostics Ltd. Analyzing rna for diagnosing infection type
WO2017153982A1 (fr) 2016-03-06 2017-09-14 Yeda Research And Development Co. Ltd. Procédé de modulation de la myélinisation
IL244649A0 (en) 2016-03-17 2016-06-30 Yeda Res & Dev Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
US10421785B2 (en) 2016-04-11 2019-09-24 Bar-Ilan University Delta receptor agonist peptides and use thereof
CA3021914A1 (fr) 2016-04-27 2017-11-02 Gen-Probe Incorporated Reactif de lyse de cellules sanguines
WO2017203520A1 (fr) 2016-05-22 2017-11-30 Yeda Research And Development Co. Ltd. Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance
IL245861A0 (en) 2016-05-25 2016-09-04 Yeda Res & Dev Use of substances to treat drug-resistant tumors
US20190100732A1 (en) 2016-06-02 2019-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
WO2017212476A1 (fr) 2016-06-05 2017-12-14 Tel Hashomer Medical Research Infrastructure And Services Ltd. Nouvelles molécules destinées au traitement de l'inflammation
EP3468610A1 (fr) 2016-06-09 2019-04-17 OPKO Biologics Ltd. Formulation d'oxyntomoduline à action prolongée, et procédés de production et procédés d'administration de cette dernière
EP3472342A1 (fr) 2016-06-19 2019-04-24 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
MX2019000022A (es) 2016-06-27 2019-09-18 Yeda Res & Dev Células veto generadas a partir de linfocitos t de memoria.
JP7112966B2 (ja) 2016-06-30 2022-08-04 シーメンス ヘルシニアーズ ネイザランド ビー．ブイ． 複数の細胞を含む体液試料内で分析物を検出するための装置、システム及び方法
US11340223B2 (en) 2016-07-10 2022-05-24 Memed Diagnostics Ltd. Early diagnosis of infections
EP4141448A1 (fr) 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Signatures protéiques permettant de faire la distinction entre des infections bactériennes et virales
KR20190038833A (ko) 2016-07-11 2019-04-09 보누스 테라퓨틱스 리미티드 조직 재생용 세포 조성물
EP4303228A3 (fr) 2016-07-11 2024-03-13 OPKO Biologics Ltd. Facteur vii de coagulation à action prolongée et procédés de production associés
EP3481191A2 (fr) 2016-07-11 2019-05-15 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Systeme et procédé pour la croissance des cellules
IL246722A0 (en) 2016-07-11 2016-09-29 Yeda Res & Dev Combined treatment to increase endogenous synthesis of nitric oxide
US20190203270A1 (en) 2016-07-24 2019-07-04 Yeda Research And Development Co., Ltd. Methods and kits for analyzing dna binding moieties attached to dna
ES2965761T3 (es) 2016-08-08 2024-04-16 Tech Innovation Momentum Fund Israel Limited Partnership Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
EP3504553B1 (fr) 2016-08-10 2022-04-20 Memed Diagnostics Ltd. Système et procédé d'analyse de données biologiques
CA3033951A1 (fr) 2016-08-14 2018-02-22 Daniel Offen Exosomes derives de cellules mesenchymateuses pour traiter des troubles neurologiques
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
WO2018037416A1 (fr) 2016-08-25 2018-03-01 Yeda Research And Development Co. Ltd. Procédés et compositions pour le traitement de maladies auto-immunes
JP2020501506A (ja) 2016-09-07 2020-01-23 イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー． 抗ＮＫｐ４６抗体およびその治療的使用
US11485971B2 (en) 2016-09-14 2022-11-01 Yeda Research And Development Co. Ltd. CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
WO2018060998A1 (fr) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Méthodes de pronostic et de traitement
IL248468A0 (en) 2016-10-13 2017-01-31 Technion Res & Dev Foundation Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
IL248385A0 (en) 2016-10-18 2017-02-01 Yeda Res & Dev Treatment of circadian rhythm disorder
US20190359956A1 (en) 2016-11-10 2019-11-28 Yeda Research And Development Co. Ltd. Phosphotriesterases for treating or preventing organophosphate exposure associated damage
EP3545095A1 (fr) 2016-11-28 2019-10-02 Yeda Research and Development Co., Ltd. Polynucléotides et polypeptides isolés et procédés pour les utiliser afin d'exprimer un produit d'expression d'intérêt
WO2018100574A1 (fr) 2016-11-30 2018-06-07 Yeda Research And Development Co. Ltd. Méthodes de traitement de maladies et de la toxicité hépathique
WO2018100511A1 (fr) 2016-12-01 2018-06-07 Ramot At Tel-Aviv University Ltd. Traitement combiné pour lésions nerveuses
CN110392736A (zh) 2017-01-18 2019-10-29 耶达研究及发展有限公司 遗传修饰的反抑细胞及其在免疫治疗中的用途
IL250479A0 (en) 2017-02-06 2017-03-30 Sorek Rotem Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
IL250916A0 (en) 2017-03-02 2017-06-29 Geiger Benjamin Methods for growing t cells in culture and their use
EP3596469A1 (fr) 2017-03-12 2020-01-22 Yeda Research and Development Co., Ltd. Procédés de diagnostic et de pronostic du cancer
WO2018167780A1 (fr) 2017-03-12 2018-09-20 Yeda Research And Development Co. Ltd. Méthodes de diagnostic et de traitement du cancer
IL269363B2 (en) 2017-03-16 2024-02-01 Lineage Cell Therapeutics Inc Methods for measuring medical effects of treating retinal diseases
CN110678543B (zh) 2017-04-05 2024-04-09 耶达研究及发展有限公司 体外培养系统及其使用方法
IL252151A0 (en) 2017-05-07 2017-07-31 Fainzilber Michael Treatment of stress disorders
CN110831966A (zh) 2017-05-10 2020-02-21 阿里埃勒科学创新有限公司 纯化抗体的方法
US11714089B2 (en) 2017-05-21 2023-08-01 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Combination of markers for diagnosing cancer
EP3634991A1 (fr) 2017-05-23 2020-04-15 Technion Research & Development Foundation Limited Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
GB201708662D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing shelf-life of banana
EP3630973A1 (fr) 2017-05-31 2020-04-08 Tropic Biosciences UK Limited Méthodes de sélection de cellules comprenant des événements d'édition de génome
GB201708665D0 (en) 2017-05-31 2017-07-12 Tropic Biosciences Uk Ltd Compositions and methods for increasing extractability of solids from coffee beans
WO2018229764A1 (fr) 2017-06-13 2018-12-20 Yeda Research And Development Co. Ltd. Traitement de la sclérose en plaques avancée ou progressive
US11466323B2 (en) 2017-07-13 2022-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
EP3652342A1 (fr) 2017-07-13 2020-05-20 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Détection d'adn spécifique d'un tissu
WO2019012543A1 (fr) 2017-07-13 2019-01-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
IL253642A0 (en) 2017-07-24 2017-09-28 Seger Rony Combined treatment for cancer
IL253984A0 (en) 2017-08-14 2017-09-28 Yeda Res & Dev Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
WO2019038771A1 (fr) 2017-08-23 2019-02-28 Technion Research & Development Foundation Limited Compositions et procédés d'amélioration de la tolérance à l'alcool dans la levure
EP3684929A1 (fr) 2017-09-19 2020-07-29 Tropic Biosciences UK Limited Modification de la spécificité de molécules d'arn non codantes pour le silençage de l'expression génique dans des cellules eucaryotes
CA3082365A1 (fr) 2017-11-09 2019-05-16 Pinteon Therapeutics Inc. Methodes et compositions pour la generation et l'utilisation d'anticorps tau phosphoryles specifiques a une conformation humanisee
IL255664A0 (en) 2017-11-14 2017-12-31 Shachar Idit Hematopoietic stem cells with enhanced properties
EP3717032B1 (fr) 2017-11-29 2023-02-15 Ramot at Tel-Aviv University Ltd. Procédés de traitement prophylactique ou thérapeutique de choc neurogénique
WO2019106667A1 (fr) 2017-11-29 2019-06-06 Weedout Ltd. Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
EP3716993A1 (fr) 2017-12-03 2020-10-07 Yeda Research and Development Co. Ltd Traitement d'une maladie cardiaque ischémique
EP3723785A1 (fr) 2017-12-17 2020-10-21 Yeda Research and Development Co. Ltd Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
EP3731965A1 (fr) 2017-12-28 2020-11-04 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
IL257225A (en) 2018-01-29 2018-04-09 Yeda Res & Dev Treatment of sarcoma
IL257269A (en) 2018-01-31 2018-04-09 Olender Tsviya Signaling is directed to the endoplasmic reticulum
EP3749689A1 (fr) 2018-02-08 2020-12-16 Yeda Research and Development Co. Ltd Inhibiteurs du protéasome 20s
WO2019155465A1 (fr) 2018-02-08 2019-08-15 Yeda Research And Development Co. Ltd. Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
EP3755340A4 (fr) 2018-02-23 2021-11-17 Carmel-Haifa University Economic Corporation Ltd. Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
WO2019167047A1 (fr) 2018-02-28 2019-09-06 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Méthodes de diagnostic et de traitement du cancer de la vessie
WO2019175869A1 (fr) 2018-03-12 2019-09-19 Yeda Research And Development Co. Ltd Traitement d'une maladie cardiaque
EP3774047A1 (fr) 2018-03-29 2021-02-17 Yeda Research and Development Co. Ltd Utilisation de gradients de champ électrique pour commander l'expression génique
US11648260B2 (en) 2018-03-29 2023-05-16 Technion Research And Development Foundation Limitted Vesicles comprising a PTEN inhibitor and uses of same
IL258467A (en) 2018-03-29 2018-07-04 Ilana Kolodkin Gal Methods of disrupting a biofilm and/or preventing formation of same
GB201807192D0 (en) 2018-05-01 2018-06-13 Tropic Biosciences Uk Ltd Compositions and methods for reducing caffeine content in coffee beans
WO2019220441A1 (fr) 2018-05-15 2019-11-21 Hadasit Medical Research Services And Development Ltd. Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
IL259392A (en) 2018-05-15 2018-08-01 Yeda Res & Dev Vaccination with cancer neo-antigens
MX2020012534A (es) 2018-05-27 2021-04-28 Biolinerx Ltd Agi-134 combinado con un inhibidor de punto de control para el tratamiento de tumores solidos.
CN112384063A (zh) 2018-06-07 2021-02-19 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 再生及转殖大麻的方法
CN112424365A (zh) 2018-06-07 2021-02-26 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 核酸构建体及其使用方法
US11873322B2 (en) 2018-06-25 2024-01-16 Yeda Research And Development Co. Ltd. Systems and methods for increasing efficiency of genome editing
US20210292381A1 (en) 2018-07-04 2021-09-23 Ukko Inc. Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
EP3818529A2 (fr) 2018-07-08 2021-05-12 Yeda Research and Development Co. Ltd Évaluation spécifique à une personne de la sensibilité aux probiotiques
WO2020012478A2 (fr) 2018-07-11 2020-01-16 Immunity Pharma Ltd. Composés peptidiques et leurs utilisations thérapeutiques
SG11202013167UA (en) 2018-07-11 2021-01-28 Kahr Medical Ltd SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
EP3827087A1 (fr) 2018-07-31 2021-06-02 CollPlant Ltd. Événement transgénique du tabac et procédés de détection et d'utilisation associés
IL261156A (en) 2018-08-14 2020-02-27 Fass Deborah Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
WO2020039440A1 (fr) 2018-08-24 2020-02-27 Yeda Research And Development Co. Ltd. Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
WO2020058979A2 (fr) 2018-09-20 2020-03-26 Yeda Research And Development Co. Ltd. Méthodes de traitement de la sclérose latérale amyotrophique
EP3856225A1 (fr) 2018-09-25 2021-08-04 BioLineRx Ltd. Procédés de sélection d'un traitement contre un cancer associé aux récepteurs cxcr4
IL262658A (en) 2018-10-28 2020-04-30 Memorial Sloan Kettering Cancer Center Prevention of age related clonal hematopoiesis and diseases associated therewith
IL263184A (en) 2018-11-21 2020-05-31 Yarden Yosef Method of treating cancer and compositions for same
WO2020152686A1 (fr) 2019-01-23 2020-07-30 Yeda Research And Development Co. Ltd. Milieux de culture pour cellules souches pluripotentes
IL264768A (en) 2019-02-10 2020-08-31 Sagi Irit ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
IL264854A (en) 2019-02-14 2020-08-31 Bahat Anat Spt5 inhibitors and methods of use thereof
JP2022521010A (ja) 2019-02-21 2022-04-04 イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド 薬物誘導性腎毒性を減少させるための方法
WO2020170239A1 (fr) 2019-02-21 2020-08-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
EP3934417A1 (fr) 2019-03-05 2022-01-12 The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) Oiseaux à édition de génome
GB201903520D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
GB201903521D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd No title
GB201903519D0 (en) 2019-03-14 2019-05-01 Tropic Biosciences Uk Ltd Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
IL265486A (en) 2019-03-19 2020-09-30 Yeda Res & Dev Bistable type ii opsins and uses thereof
WO2020194317A1 (fr) 2019-03-28 2020-10-01 Yeda Research And Development Co. Ltd. Méthode de traitement de troubles liés aux lipides
EP3946611A2 (fr) 2019-03-31 2022-02-09 Yeda Research and Development Co. Ltd Composés anti-viraux et anti-tumoraux
IL266433B (en) 2019-05-02 2020-11-30 Sagi Irit Compositions comprising the propeptide of lysyl oxidase and uses thereof
EP3969619A1 (fr) 2019-05-13 2022-03-23 Yeda Research and Development Co. Ltd Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
IL266728B (en) 2019-05-19 2020-11-30 Yeda Res & Dev Identification of recurrent mutant neopeptides
AU2020279080A1 (en) 2019-05-22 2022-01-20 Hadasit Medical Research Services And Development Ltd. Methods of culturing human pluripotent cells
CN114599675A (zh) 2019-05-28 2022-06-07 上海科技大学 用于治疗clouston型外胚层发育不良2的组合物和方法
US20220233477A1 (en) 2019-06-12 2022-07-28 Hadasit Medical Research Services And Development Ltd. Methods of generating oligodendrocytes
US20220307008A1 (en) 2019-06-16 2022-09-29 Yeda Research And Development Co. Ltd. Method for stabilizing intracellular rna
EP3990488A4 (fr) 2019-06-27 2023-09-13 Ramot at Tel-Aviv University Ltd. Anticorps semaphorine 3a et leurs utilisations
EP3994268A1 (fr) 2019-07-04 2022-05-11 Ukko Inc. Alpha gliadine sans épitope et son utilisation pour la gestion de la maladie coeliaque et de la sensibilité au gluten
JP2022541742A (ja) 2019-07-11 2022-09-27 カール メディカル リミテッド ヘテロダイマーおよびその使用方法
US20220281960A1 (en) 2019-07-16 2022-09-08 Ramot At Tel-Aviv University Ltd. Compositions and methods for the treatment of tuberculosis
IL268111A (en) 2019-07-16 2021-01-31 Fainzilber Michael Methods of treating pain
WO2021019526A1 (fr) 2019-07-29 2021-02-04 Yeda Research And Development Co. Ltd. Procédés de traitement et de diagnostic du cancer du poumon
EP4004212A1 (fr) 2019-07-30 2022-06-01 The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) Méthodes de régulation de la synthèse de cannabinoïdes chez la plante ou dans des cellules et plantes et cellules ainsi produites
EP4014046A1 (fr) 2019-08-12 2022-06-22 Yeda Research and Development Co. Ltd Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
WO2021033176A1 (fr) 2019-08-22 2021-02-25 Ariel Scientific Innovations Ltd. Procédés mis à l'échelle de purification d'anticorps
EP4021463A1 (fr) 2019-08-27 2022-07-06 Yeda Research and Development Co. Ltd Traitement de la vaginose bactérienne
WO2021048852A1 (fr) 2019-09-11 2021-03-18 Yeda Research And Development Co. Ltd. Méthodes de traitement du cancer du sein
IL269674B (en) 2019-09-25 2020-08-31 Roy Bar Ziv Assembling protein complexes on a chip
IL270306A (en) 2019-10-30 2021-05-31 Yeda Res & Dev Prevention and treatment of pre-myeloid and myeloid malignancies
US20240117386A1 (en) 2019-10-31 2024-04-11 Yeda Research And Development Co. Ltd. Engineered autotrophic bacteria for co2 conversion to organic materials
MX2022005678A (es) 2019-11-11 2022-10-18 Ibi Ag Innovative Bio Insecticides Ltd Nanocuerpos para el control de insectos y usos de los mismos.
WO2021100034A1 (fr) 2019-11-19 2021-05-27 Protalix Ltd. Élimination de constructions à partir de cellules transformées
IL270800A (en) 2019-11-20 2021-05-31 Yeda Res & Dev A method for treating Alzheimer's disease
IL271656A (en) 2019-12-22 2021-06-30 Yeda Res & Dev System and methods for identifying cells that have undergone genome editing
EP4077731A1 (fr) 2019-12-22 2022-10-26 Yeda Research and Development Co. Ltd Diagnostic de la démence frontotemporale
WO2021137231A1 (fr) 2019-12-31 2021-07-08 Kahr Medical Ltd. Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
US20230048361A1 (en) 2019-12-31 2023-02-16 Kahr Medical Ltd. Methods of culturing t cells and uses of same
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
IL272074A (en) 2020-01-15 2021-07-29 Immunity Pharma Ltd Peptide compounds and their use in methods of treating diseases
IL272194A (en) 2020-01-22 2021-07-29 Yeda Res & Dev Multi-target antibodies for use in the treatment of diseases
WO2021152584A1 (fr) 2020-01-28 2021-08-05 Ariel Scientific Innovations Ltd. Procédés d'analyse de membranes cellulaires
IL272390A (en) 2020-01-30 2021-08-31 Yeda Res & Dev Cancer treatment methods
IL272389A (en) 2020-01-30 2021-08-31 Yeda Res & Dev Kits containing antibodies to PD-L1 and their uses in therapy
EP4096647A1 (fr) 2020-01-30 2022-12-07 Yeda Research and Development Co. Ltd Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
WO2021152586A1 (fr) 2020-01-30 2021-08-05 Yeda Research And Development Co. Ltd. Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
IL295500A (en) 2020-02-09 2022-10-01 Nlc Pharma Ltd Rapid detection test for sars-cov-2
IL272586A (en) 2020-02-10 2021-08-31 Yeda Res & Dev A method for cell cluster analysis
WO2021173674A1 (fr) 2020-02-26 2021-09-02 A2 Biotherapeutics, Inc. Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
WO2021186431A1 (fr) 2020-03-16 2021-09-23 Yeda Research And Development Co. Ltd. Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
AU2021245409A1 (en) 2020-03-29 2022-11-24 Yeda Research And Development Co. Ltd. Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
CN115484836A (zh) 2020-03-31 2022-12-16 百欧穆斯有限公司 用于预防和治疗烟雾诱发的肺部损伤的细菌
WO2021205444A1 (fr) 2020-04-06 2021-10-14 Yeda Research And Development Co. Ltd. Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
WO2021205459A1 (fr) 2020-04-07 2021-10-14 Ramot At Tel-Aviv University Ltd. Compositions contenant du cannabidiol et leurs utilisations
EP4135746A1 (fr) 2020-04-13 2023-02-22 Exoprother Medical Ltd. Vésicules dérivées de cellules comprenant une protéine p53 de type sauvage pour une thérapie antivirale
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
WO2021229577A1 (fr) 2020-05-12 2021-11-18 Collplant Ltd. Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
IL274811B (en) 2020-05-20 2021-05-31 Yeda Res & Dev Spatial information is developed for the analysis of individual cells
WO2021260675A1 (fr) 2020-06-24 2021-12-30 Yeda Research And Development Co. Ltd. Agents pour sensibiliser des tumeurs solides à un traitement
IL276599A (en) 2020-08-09 2022-03-01 Yeda Res & Dev T cell receptor unique to mage-a1 and its uses
IL276627A (en) 2020-08-10 2022-03-01 Yeda Res & Dev Compositions for diagnosis and treatment of coronavirus infections
US20230309480A1 (en) 2020-08-18 2023-10-05 International Rice Research Institute Methods of increasing outcrossing rates in gramineae
IL277488A (en) 2020-09-21 2022-04-01 Yeda Res & Dev Weight regulation method
IL301503A (en) 2020-09-23 2023-05-01 Yeda res & development co ltd Methods and preparations for the treatment of the disease caused by the corona virus
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
KR20230113283A (ko) 2020-10-05 2023-07-28 프로탈릭스 리미티드 다이서-유사 넉아웃 식물 세포
JP2023545740A (ja) 2020-10-07 2023-10-31 プロタリクス リミテッド 長期活性ＤＮａｓｅ
WO2022079719A1 (fr) 2020-10-15 2022-04-21 Yeda Research And Development Co. Ltd. Méthode de traitement des cancers myéloïdes
IL278401A (en) 2020-10-29 2022-05-01 Yeda Res & Dev Polynucleotides for editing RNA and a method for using them
WO2022097157A2 (fr) 2020-11-09 2022-05-12 1E Therapeutics, Ltd. Méthodes de traitement ou de prévention d'infections bactériennes faisant appel à une séquence catalytique
CA3200350A1 (fr) 2020-11-26 2022-06-02 Yanay OFRAN Sous-unite de glutenine modifiee a poids moleculaire eleve et ses utilisations
IL279559A (en) 2020-12-17 2022-07-01 Yeda Res & Dev Controlling the ubiquitination process of mlkl for disease treatment
KR20230133859A (ko) 2020-12-28 2023-09-19 1이 테라퓨틱스 엘티디. p21 mRNA 표적화 DNA자임
EP4267741A2 (fr) 2020-12-28 2023-11-01 1E Therapeutics, Ltd. Zones cibles de l'arnm p21 pour le silençage
AU2022206415A1 (en) 2021-01-10 2023-08-17 Supermeat The Essence Of Meat Ltd. Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
WO2022153286A1 (fr) 2021-01-14 2022-07-21 Yeda Research And Development Co. Ltd. Procédés de production de vitamine d
IL280340B (en) 2021-01-21 2022-04-01 Yeda Res & Dev Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
JP2024506954A (ja) 2021-02-18 2024-02-15 イェダ リサーチ アンド デベロップメント カンパニー リミテッド ワクチン作製用の遺伝子改変細菌
IL305315A (en) 2021-02-18 2023-10-01 Yeda res & development co ltd Methods for producing vaccines
IL281561A (en) 2021-03-16 2022-10-01 Yeda Res & Dev Methods and devices for growing mouse embryos outside the uterus
EP4313091A1 (fr) 2021-03-30 2024-02-07 Biomx Ltd. Bactériophage de pseudomonas et ses utilisations
IL282188A (en) 2021-04-08 2022-11-01 Yeda Res & Dev Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
AU2022272135A1 (en) 2021-05-12 2024-01-04 Biomx Ltd. Staphylococcus bacteriophage and uses thereof
IL283563A (en) 2021-05-30 2022-12-01 Yeda Res & Dev Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
IL309061A (en) 2021-06-06 2024-02-01 Yeda res & development co ltd Combined cancer treatment
WO2022264132A1 (fr) 2021-06-13 2022-12-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédé de reprogrammation de cellules humaines
WO2022264076A1 (fr) 2021-06-16 2022-12-22 Seedx Technologies Inc. Procédés de tri de graines de matthiola
NL2028466B1 (en) 2021-06-16 2022-12-21 Sakata Holland B V Methods of sorting matthiola seeds
CA3223344A1 (fr) 2021-07-02 2023-01-05 Tropic Biosciences UK Limited Retardement ou prevention du brunissement de bananes
IL310226A (en) 2021-07-18 2024-03-01 Gamida Cell Ltd NK cell populations for treatment
WO2023002492A1 (fr) 2021-07-22 2023-01-26 Yeda Research And Development Co. Ltd. Optimisation de codon d'acides nucléiques
WO2023012798A2 (fr) 2021-08-02 2023-02-09 Yeda Research And Development Co. Ltd. Anticorps pour le traitement du cancer
EP4130028A1 (fr) 2021-08-03 2023-02-08 Rhazes Therapeutics Ltd Complexe tcr modifié et leurs procédés d'utilisation
CA3226947A1 (fr) 2021-08-03 2023-02-09 Muhammad YASSIN Complexe tcr modifie et ses procedes d'utilisation
WO2023018621A1 (fr) 2021-08-10 2023-02-16 Gamida-Cell Ltd. Cellules nk modifiées, leurs procédés de production et leurs utilisations
GB202112865D0 (en) 2021-09-09 2021-10-27 Tropic Biosciences Uk Ltd Resistance to black sigatoka disease in banana
GB202112866D0 (en) 2021-09-09 2021-10-27 Tropic Biosciences Uk Ltd Resistance to fusarium wilt in a banana
IL286430A (en) 2021-09-14 2023-04-01 Yeda Res & Dev Multispecific antibodies for use in the treatment of diseases
WO2023105526A1 (fr) 2021-12-08 2023-06-15 Yeda Research And Development Co. Ltd. Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
WO2023144798A1 (fr) 2022-01-31 2023-08-03 Genevant Sciences Gmbh Lipides cationiques ionisables pour nanoparticules lipidiques
WO2023209708A1 (fr) 2022-04-25 2023-11-02 Yeda Research And Development Co. Ltd. Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091697A (en) * 1955-03-03 1963-05-28 Ethel D Armbrecht Photomultiplier control circuit
US3708402A (en) * 1970-10-19 1973-01-02 Gen Electric Measurements of particles and molecules
US3762877A (en) * 1971-05-24 1973-10-02 Bausch & Lomb Method of and apparatus for depositing a fluid in a gel
BE789188A (fr) * 1971-09-24 1973-01-15 Orion Yhtymae Oy Procede pour la determination quantitative et qualitative de molecules ayant des proprietes antigenes
US3732014A (en) * 1972-01-31 1973-05-08 Gen Electric Electromagnetic radiation apparatus for analyzing small particles
US3819505A (en) * 1972-03-09 1974-06-25 Becton Dickinson Co Testing apparatus
US3793180A (en) * 1972-03-21 1974-02-19 Singer Co Laser-recticle electrophoresis instrument
US3764512A (en) * 1972-05-02 1973-10-09 Singer Co Laser scanning electrophoresis instrument and system
US3873432A (en) * 1972-10-30 1975-03-25 Louis Israel Continuous preparative electrophoresis method
US3766048A (en) * 1972-11-24 1973-10-16 Univ Illinois Analysis of polymer mixtures in solution utilizing electrophoretic light scattering apparatus
US3912610A (en) * 1974-07-23 1975-10-14 Icl Scient Method for electroquantitative determination of proteins
US3984533A (en) * 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction

Also Published As

Publication number Publication date
FR2331793A1 (fr) 1977-06-10
JPS5270018A (en) 1977-06-10
DE2651388A1 (de) 1977-05-26
GB1542493A (en) 1979-03-21
US3984533A (en) 1976-10-05

Similar Documents

Publication Publication Date Title
FR2331793B1 (fr)
FR2327854B1 (fr)
JPS5710882B2 (fr)
JPS5218355U (fr)
JPS5528295Y2 (fr)
JPS5711128B2 (fr)
JPS5190757U (fr)
JPS5189903A (fr)
JPS5230288U (fr)
JPS5259656U (fr)
JPS51150200U (fr)
JPS5274730U (fr)
JPS5239388U (fr)
JPS5214211U (fr)
CH606939A5 (fr)
CH603802A5 (fr)
BG22446A1 (fr)
BG21662A1 (fr)
CH607956A5 (fr)
CH607380A5 (fr)
CH607308A5 (fr)
CH607214A5 (fr)
CH607059A5 (fr)
CH606582A5 (fr)
BG26417A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse